Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
12000,,,15600942,[],CHEMBL3579606,Antimicrobial activity against Proteus mirabilis GN2425,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3576789,J Med Chem,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479978,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,12.5
12001,,,15600945,[],CHEMBL3579605,Antimicrobial activity against Klebsiella pneumoniae PCI602,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3576789,J Med Chem,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479978,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,6.25
12002,,,15600948,[],CHEMBL3579604,Antimicrobial activity against Klebsiella pneumoniae 602,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3576789,J Med Chem,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479978,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,6.25
12003,,,15600951,[],CHEMBL3579603,Antimicrobial activity against Escherichia coli NIHJ JC2,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3576789,J Med Chem,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479978,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,6.25
12004,,,15600954,[],CHEMBL3579602,Antimicrobial activity against Escherichia coli NIHJ,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3576789,J Med Chem,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479978,=,1,1,=,,MIC,ug.mL-1,,3.13,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,3.13
12005,,,15693613,[],CHEMBL3610983,Antimicrobial activity against Streptococcus pyogenes ATCC 19615 incubated for 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3608264,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,2497753,=,1,1,=,,MIC,nM,,3772400.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,uM,UO_0000065,,3772.4
12006,,,15693641,[],CHEMBL3610982,Antimicrobial activity against Staphylococcus aureus ATCC 25923 incubated for 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3608264,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,2497753,=,1,1,=,,MIC,nM,,3772400.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,3772.4
12007,,,15693667,[],CHEMBL3610984,Antimicrobial activity against Salmonella typhimurium ATCC 19430 incubated for 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3608264,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,2497753,=,1,1,=,,MIC,nM,,7200.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,uM,UO_0000065,,7.2
12008,,,15693695,[],CHEMBL3610985,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3608264,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,2497753,=,1,1,=,,MIC,nM,,14500.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,14.5
12009,,,15713612,[],CHEMBL3620745,Antibacterial activity against Staphylococcus aureus at 10 ug/disk after 24 hrs by agar plate disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Millimeter,2502100,=,1,1,=,,IZ,mm,,27.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,27.0
12010,,,15713622,[],CHEMBL3620746,Antibacterial activity against Escherichia coli at 10 ug/disk after 24 hrs by agar plate disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Millimeter,2502100,=,1,1,=,,IZ,mm,,26.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,26.0
12011,,,15713632,[],CHEMBL3620747,Antibacterial activity against Proteus vulgaris at 10 ug/disk after 24 hrs by agar plate disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Millimeter,2502100,=,1,1,=,,IZ,mm,,25.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,DIZ,mm,UO_0000016,,25.0
12012,,,15713642,[],CHEMBL3620748,Antibacterial activity against Pseudomonas aeruginosa at 10 ug/disk after 24 hrs by agar plate disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Millimeter,2502100,=,1,1,=,,IZ,mm,,22.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,DIZ,mm,UO_0000016,,22.0
12013,,,15713652,[],CHEMBL3620749,Antibacterial activity against Salmonella typhi at 10 ug/disk after 24 hrs by agar plate disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Millimeter,2502100,=,1,1,=,,IZ,mm,,25.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,DIZ,mm,UO_0000016,,25.0
12014,,,15713662,[],CHEMBL3620750,Antibacterial activity against Salmonella paratyphi at 10 ug/disk after 24 hrs by agar plate disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Millimeter,2502100,=,1,1,=,,IZ,mm,,24.0,CHEMBL612293,Salmonella enterica subsp. enterica serovar Paratyphi A,Salmonella paratyphi,54388.0,,,DIZ,mm,UO_0000016,,24.0
12015,,,15713672,[],CHEMBL3620751,Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by micro alamar blue assay,F,,,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,2502100,=,1,1,=,,Inhibition,%,,63.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,INH,%,UO_0000187,,63.0
12016,,,15713682,[],CHEMBL3620752,Antibacterial activity against Staphylococcus aureus after 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502100,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
12017,,,15713692,[],CHEMBL3620753,Antibacterial activity against Staphylococcus aureus after 5 days by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502100,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
12018,,,15713702,[],CHEMBL3620754,Antibacterial activity against Escherichia coli after 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502100,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
12019,,,15713712,[],CHEMBL3620755,Antibacterial activity against Escherichia coli after 5 days by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502100,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
12020,,,15713722,[],CHEMBL3620756,Antibacterial activity against Proteus vulgaris after 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502100,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.25
12021,,,15713732,[],CHEMBL3620899,Antibacterial activity against Proteus vulgaris after 5 days by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502100,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.25
12022,,,15713742,[],CHEMBL3620900,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502100,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
12023,,,15713752,[],CHEMBL3620901,Antibacterial activity against Pseudomonas aeruginosa after 5 days by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502100,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
12024,,,15713762,[],CHEMBL3620902,Antibacterial activity against Salmonella typhi after 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502100,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,1.0
12025,,,15713772,[],CHEMBL3620903,Antibacterial activity against Salmonella typhi after 5 days by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502100,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,1.0
12026,,,15713782,[],CHEMBL3620904,Antibacterial activity against Salmonella paratyphi after 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502100,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612293,Salmonella enterica subsp. enterica serovar Paratyphi A,Salmonella paratyphi,54388.0,,,MIC,ug ml-1,UO_0000274,,1.0
12027,,,15713792,[],CHEMBL3620905,Antibacterial activity against Salmonella paratyphi after 5 days by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502100,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612293,Salmonella enterica subsp. enterica serovar Paratyphi A,Salmonella paratyphi,54388.0,,,MIC,ug ml-1,UO_0000274,,1.0
12028,,328072,17706662,[],CHEMBL3887280,"null: A commercially available P450-GLO Assay kit (Promega Corporation, Madison Wis.) is used to screen various compounds for CYP3A4A inhibition activity. CYP3A4A is thought to be one of the primary CYP isoforms responsible for retinoic acid metabolism in the skin. Three benchmark agents, liarozole, climbazole, and ketoconazole, were assessed for CYP3A4 inhibition to confirm that the inhibition activity (the IC50 for CYP3A4 inhibition) measured by the assay corresponds to the activity reported by the published literature. The results show that the substituted azole compounds having the specific structure set forth herein are CYP inhibitors, and thus function as RAMBAs.",B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3886254,,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,1,http://www.openphacts.org/units/Nanomolar,2839442,>,37,1,>,,IC50,nM,,10000.0,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,IC50,nM,UO_0000065,,10000.0
12029,,328868,17707458,[],CHEMBL3887294,"In vitro CYP3A4 Inhibition Assay: Cytochrome P450 is a large and diverse group of enzymes that catalyze the oxidation of organic substances. Some members of the CYP family contribute to the elimination of ATRA by catalyzing its 4-hydroxylation in the mammalian liver and skin, including that of humans as well as swine. Applicant evaluated the potential RAMBA activity of several azoles using pig liver microsomes, a rich source of CYP activity, comprising many different CYP 450 isoforms. Therefore, this approach, while a reasonable way to assess CYP inhibitors with broad activities may or may not be the best way to discover RAMBAs with selectivity for the skin, which has a much more narrow complement of CYP expression. As understanding in this area has progressed, a more specific CYP inhibition assay can be used to provide better predictivity of activity in human skin. Nevertheless, this assay may still be used as a general predictor of overall CYP activity.",B,,,BAO_0000190,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL3886263,,2015.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,2840124,>,37,1,>,,IC50,nM,,10000.0,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,IC50,nM,UO_0000065,,10000.0
12030,,,18129166,[],CHEMBL4028921,Inhibition of human BSEP overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-taurocholate in presence of ATP measured after 15 to 20 mins by membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3006504,>,1,1,>,,IC50,nM,,133000.0,CHEMBL6020,Homo sapiens,Bile salt export pump,9606.0,,,IC50,uM,UO_0000065,,133.0
12031,,,18129749,[],CHEMBL4028922,Inhibition of human MRP2 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3006504,>,1,1,>,,IC50,nM,,133000.0,CHEMBL5748,Homo sapiens,Canalicular multispecific organic anion transporter 1,9606.0,,,IC50,uM,UO_0000065,,133.0
12032,,,18130336,[],CHEMBL4028923,Inhibition of human MRP3 overexpressed in Sf9 insect cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 10 mins by membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3006504,>,1,1,>,,IC50,nM,,133000.0,CHEMBL5918,Homo sapiens,Canalicular multispecific organic anion transporter 2,9606.0,,,IC50,uM,UO_0000065,,133.0
12033,,,18130936,[],CHEMBL4028924,Inhibition of human MRP4 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,4.24,0,http://www.openphacts.org/units/Nanomolar,3006504,=,1,1,=,,IC50,nM,,57500.0,CHEMBL1743128,Homo sapiens,Multidrug resistance-associated protein 4,9606.0,,,IC50,uM,UO_0000065,,57.5
12034,,,18133253,[],CHEMBL4029349,Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index,T,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4028802,Drug Discov Today,2016.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,3007651,=,1,0,=,,DILI_severity_class,,,3.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,DILI_severity_class,,,,3.0
12035,,Ambiguous-Dili-Concern,18133582,[],CHEMBL4029350,Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status,T,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4028802,Drug Discov Today,2016.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,3007651,,1,0,,,DILI_Concern,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,DILI_Concern,,,,
12036,,Active,18182172,[],CHEMBL4039940,Antibacterial activity against Bacillus subtilis assessed as inhibition of DNA synthesis at 100 mg/L after 50 mins by [3H]thymidine incorporation assay,F,,,BAO_0000201,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4038308,J Med Chem,2017.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,3016287,,1,0,,,Inhibition,%,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,INH,,UO_0000187,,
12037,,Active,18182180,[],CHEMBL4039945,Antibacterial activity against Bacillus subtilis assessed as inhibition of RNA synthesis at 100 mg/L after 50 mins by [3H]-uridine incorporation assay,F,,,BAO_0000201,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4038308,J Med Chem,2017.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,3016287,,1,0,,,Inhibition,%,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,INH,,UO_0000187,,
12038,,Active,18182188,[],CHEMBL4039950,Antibacterial activity against Bacillus subtilis assessed as inhibition of peptidoglycan synthesis at 100 mg/L after 50 mins by [3H]-N-acetylglucosamine incorporation assay,F,,,BAO_0000201,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4038308,J Med Chem,2017.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,3016287,,1,0,,,Inhibition,%,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,INH,,UO_0000187,,
12039,,Active,18182196,[],CHEMBL4039955,Antibacterial activity against Bacillus subtilis assessed as inhibition of plasma membrane lipids synthesis at 100 mg/L after 50 mins by [3H]-sodium acetate incorporation assay,F,,,BAO_0000201,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4038308,J Med Chem,2017.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,3016287,,1,0,,,Inhibition,%,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,INH,,UO_0000187,,
12040,,Active,18182204,[],CHEMBL4039960,Antibacterial activity against Bacillus subtilis assessed as inhibition of protein synthesis at 100 mg/L after 50 mins by [35S]-methionine incorporation assay,F,,,BAO_0000201,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4038308,J Med Chem,2017.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,3016287,,1,0,,,Inhibition,%,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,INH,,UO_0000187,,
12041,,,18236835,[],CHEMBL4051382,Antibacterial activity against Escherichia coli MG1655 measured every 15 mins for 12 hrs,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4049433,J Med Chem,2017.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3026384,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,5.0
12042,,,18326895,[],CHEMBL4135472,Cytotoxicity against human HL cells assessed as cell viability at 50 uM after 72 hrs by resazurin dye based fluorescence assay relative to control,A,,,BAO_0001103,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4130515,J Nat Prod,2017.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,3042829,=,1,0,=,,Activity,%,,15.8,CHEMBL612594,Homo sapiens,HL,9606.0,,,Activity,%,UO_0000187,,15.8
12043,,,18783274,[],CHEMBL4270965,Antibacterial activity against Pseudomonas aeruginosa by broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4270488,J Nat Prod,2017.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3121120,=,1,1,=,,MIC,ug.mL-1,,1250.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,1500.0,1250.0
12044,,,18783284,[],CHEMBL4270967,Antibacterial activity Bacillus pumilus against by broth dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4270488,J Nat Prod,2017.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3121120,=,1,1,=,,MIC,ug.mL-1,,1250.0,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,1500.0,1250.0
12045,,,18829039,[],CHEMBL4303805,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4303101,,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,3135537,=,52,1,=,,Inhibition,%,,-0.44,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,Inhibition,%,UO_0000187,,-0.44
12046,,,18835383,[],CHEMBL4303810,Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4303122,,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,3141653,=,52,0,=,,Hit score,,,0.03233,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,Hit score,,,,0.0323258
12047,,,18889714,[],CHEMBL4314013,Antibacterial activity against Klebsiella pneumoniae ATCC 13443 assessed as growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4311975,Eur J Med Chem,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3151705,=,1,1,=,,MIC,nM,,100000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,uM,UO_0000065,,100.0
12048,,,18889718,[],CHEMBL4313979,Antibacterial activity against Acinetobacter baumannii AYE assessed as growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4311975,Eur J Med Chem,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3151705,>,1,1,>,,MIC,nM,,200000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,uM,UO_0000065,,200.0
12049,,,18889960,[],CHEMBL4313986,Antibacterial activity against Escherichia coli ATCC 25922 assessed as growth inhibition incubated for 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4311975,Eur J Med Chem,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3151705,>,1,1,>,,MIC,nM,,200000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,200.0
12050,,,18889988,[],CHEMBL4313985,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as growth inhibition incubated for 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4311975,Eur J Med Chem,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3151705,>,1,1,>,,MIC,nM,,200000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,200.0
12051,,,18984955,[],CHEMBL4339896,Antibacterial activity against Escherichia coli ATCC 25922 measured after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4339208,Bioorg Med Chem,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3167071,>,1,1,>,,MIC,nM,,200000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,200.0
12052,,,18985005,[],CHEMBL4339897,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 measured after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4339208,Bioorg Med Chem,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3167071,>,1,1,>,,MIC,nM,,200000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,200.0
12053,,,18985023,[],CHEMBL4339898,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 measured after 18 hrs by resazurin dye based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4339208,Bioorg Med Chem,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3167071,=,1,1,=,,MIC,nM,,100000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,uM,UO_0000065,,100.0
12054,,,18985041,[],CHEMBL4339899,Antibacterial activity against Acinetobacter baumannii ATCC 19606 measured after 18 hrs by resazurin dye based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4339208,Bioorg Med Chem,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3167071,>,1,1,>,,MIC,nM,,200000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,uM,UO_0000065,,200.0
12055,,,18985124,[],CHEMBL4339908,Potentiation of nalidixic acid-induced antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as concentration required to restore 2 ug/ml nalidixic acid activity measured after 18 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4339208,Bioorg Med Chem,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Micromolar,3167071,=,1,0,=,,Activity,uM,,50.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,uM,UO_0000064,,50.0
12056,,,18985128,[],CHEMBL4339913,Potentiation of nalidixic acid-induced antibacterial activity against Escherichia coli ATCC 25922 assessed as concentration required to restore 2 ug/ml nalidixic acid activity measured after 18 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4339208,Bioorg Med Chem,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Micromolar,3167071,>,1,0,>,,Activity,uM,,200.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,uM,UO_0000064,,200.0
12057,,,18985132,[],CHEMBL4339917,Potentiation of nalidixic acid-induced antibacterial activity against Klebsiella pneumoniae ATCC 700603 assessed as concentration required to restore 2 ug/ml nalidixic acid activity measured after 18 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4339208,Bioorg Med Chem,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Micromolar,3167071,=,1,0,=,,Activity,uM,,25.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,uM,UO_0000064,,25.0
12058,,,18985136,[],CHEMBL4339921,Potentiation of nalidixic acid-induced antibacterial activity against Acinetobacter baumannii ATCC 19606 assessed as concentration required to restore 2 ug/ml nalidixic acid activity measured after 18 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4339208,Bioorg Med Chem,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Micromolar,3167071,=,1,0,=,,Activity,uM,,200.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,uM,UO_0000064,,200.0
12059,,,19030817,[],CHEMBL4349361,Inhibition of Escherichia coli DNA gyrase super-coiling activity using pBR322 DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4346717,Eur J Med Chem,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174944,=,1,1,=,,IC50,ug.mL-1,,1.74,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,ug ml-1,UO_0000274,,1.74
12060,,,19051581,[],CHEMBL4354972,Antibacterial activity against Pseudomonas aeruginosa by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178411,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,mg/L,UO_0000274,,64.0
12061,,,19051595,[],CHEMBL4354971,Antibacterial activity against Escherichia coli by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178411,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,8.0
12062,,,19051615,[],CHEMBL4354973,Antibacterial activity against Klebsiella by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178411,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC90,mg/L,UO_0000274,,16.0
12063,,,19051629,[],CHEMBL4354974,Antibacterial activity against Bacteroides fragilis by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178411,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC90,mg/L,UO_0000274,,64.0
12064,,,19051643,[],CHEMBL4354975,Antibacterial activity against Haemophilus influenzae with horse blood by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178411,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,mg/L,UO_0000274,,2.0
12065,,,19051657,[],CHEMBL4354976,Antibacterial activity against Staphylococcus aureus by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178411,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,mg/L,UO_0000274,,64.0
12066,,,19051671,[],CHEMBL4354977,Antibacterial activity against Streptococcus pneumoniae by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178411,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,mg/L,UO_0000274,,64.0
12067,,,19051685,[],CHEMBL4354978,Antibacterial activity against Streptococcus pyogenes by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178411,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,mg/L,UO_0000274,,64.0
12068,,,19051699,[],CHEMBL4354979,Antibacterial activity against Enterococcus by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178411,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC90,mg/L,UO_0000274,,64.0
12069,,,19051713,[],CHEMBL4354980,Antibacterial activity against Clostridium perfringens by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178411,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC90,mg/L,UO_0000274,,64.0
12070,,,19051718,[],CHEMBL4354981,"Half life in human at 1 g, po administered for 4 times",A,,,BAO_0002115,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Hour,3178411,=,1,1,=,,T1/2,hr,,1.5,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,1.5
12071,,,19051719,[],CHEMBL4354982,"Protein binding in human at 1 g, po administered for 4 times",A,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,3178411,=,1,1,=,,PPB,%,,90.0,CHEMBL612558,,ADMET,,,,PB,%,UO_0000187,,90.0
12072,,,19487189,[],CHEMBL4481750,Antibacterial activity against Pseudomonas aeruginosa ATCC 15442 after 24 hrs by resazurin dye based fluorescence assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4480423,J Nat Prod,2019.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3258953,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
12073,,,19956492,[],CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM  by FRET kind of response from peptide substrate,F,,,BAO_0000201,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4495564,,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,3342910,=,52,1,=,,Inhibition,%,,12.92,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,,Inhibition,%,UO_0000187,,12.92
12074,,,19961820,[],CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM  by FRET kind of response from peptide substrate,F,,,BAO_0000201,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4495564,,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,3348238,=,52,1,=,,Inhibition,%,,22.78,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,,Inhibition,%,UO_0000187,,22.78323435
12075,,,20150255,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4495565,,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,3366110,=,52,1,=,,Inhibition,%,,-0.05,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,-0.05
12076,,,20150506,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4495565,,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,3360782,=,52,1,=,,Inhibition,%,,0.12,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,0.12
12077,,Median N= 2; Maxinhib 3.0 Pct,20162469,[],CHEMBL4296189,"Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4513141,,,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3369957,>,40,1,>,,MIC,nM,,10000.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,uM,UO_0000065,,10.0
12078,,Median N= 2; Maxinhib 9.6 Pct,20162470,[],CHEMBL4296190,"Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4513141,,,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3369957,>,40,1,>,,MIC,nM,,10000.0,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,,MIC,uM,UO_0000065,,10.0
12079,,Median N= 2; Maxinhib 62.6 Pct,20162471,[],CHEMBL4296185,"Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4513141,,,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3369957,>,40,1,>,,MIC,nM,,10000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,10.0
12080,,Median N= 2; Maxinhib 13.2 Pct,20162472,[],CHEMBL4296186,"Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4513141,,,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3369957,>,40,1,>,,MIC,nM,,10000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,uM,UO_0000065,,10.0
12081,,Median N= 2; Maxinhib 42.4 Pct,20162473,[],CHEMBL4296187,"Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4513141,,,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3369957,>,40,1,>,,MIC,nM,,10000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,10.0
12082,,Median N= 2; Maxinhib 10.4 Pct,20162474,[],CHEMBL4296188,"Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4513141,,,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3369957,>,40,1,>,,MIC,nM,,10000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,uM,UO_0000065,,10.0
12083,,Median N= 2; Maxinhib 24.4 Pct,20162475,[],CHEMBL4296184,"Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4513141,,,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3369957,>,40,1,>,,MIC,nM,,10000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,10.0
12084,,Median N= 2; Maxinhib 20.9 Pct,20162476,[],CHEMBL4296191,"Cytotoxicity against HEK293 cells (CO-ADD:MA_007); CC50 by cell viability assay in DMEM (10% FBS) media using TC plates, by Resazurin F(560/590)",F,,,BAO_0000187,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4513141,,,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3369957,>,40,1,>,,CC50,nM,,10000.0,CHEMBL614818,Homo sapiens,HEK293,9606.0,,,CC50,uM,UO_0000065,,10.0
12085,,,22072272,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4495565,,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,3360782,=,52,1,=,,Inhibition,%,,0.12,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,0.12
12086,,,22077600,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4495565,,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,3366110,=,52,1,=,,Inhibition,%,,-0.05,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,-0.05
12087,,No. Measurements = 1,22086146,[],CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4651402,,2021.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3490854,>,57,1,>,,IC50,nM,,20000.0,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,IC50,M,UO_0000065,,2e-05
12088,,No. Measurements = 1,22086147,[],CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4651402,,2021.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3490854,<,57,1,>,,IC50,nM,,19952.62,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,pIC50,,UO_0000065,,4.7
12089,,,22793295,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '120.0'}]",CHEMBL4710189,"Inhibition of biotinylated 5-(4-((Z)-3-Carboxy-3-hydroxyacryloyl)-4-(4-chlorobenzyl)piperidine-1-carbonyl)-2-((13,35-dioxo-39-((3aR,4R,6aS)-2-oxohexahydro-1H-thieno[3,4-d]imidazole-4-yl)-3,6,9,16,19,22,25,28,31-nonaoxa-12,34-diazanonatriacontyl)oxy)benzoic acid binding to Influenza A virus (A/California/07/2009(H1N1)) N-terminal GST-tagged polymerase acidic subunit N-terminal domain expressed in Escherichia coli BL21 (DE3) RIL cells measured after 120 mins by Alphascreen assay",B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4706556,Eur J Med Chem,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3539407,>,1,1,>,,IC50,nM,,50000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,50.0
12090,,Not Active,22979454,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4772570,Bacteriostatic activity against Escherichia coli KCTC 1682 assessed as reduction in colony forming unit at 0.5 times MIC measured for 24 hrs by time kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4765389,Eur J Med Chem,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,3568579,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
12091,,,22988829,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4774839,Antitubercular activity against Mycobacterium tuberculosis H37Rv measured after 7 days by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4765453,Eur J Med Chem,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3570387,>,1,1,>,,MIC,nM,,50000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,50.0
12092,,,22988953,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4774856,Antitubercular activity against FQ resistant Mycobacterium tuberculosis H37Rv harboring gyrA Ala-90-Val mutant measured after 7 days by resazurin microtiter assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4765453,Eur J Med Chem,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3570387,>,1,1,>,,MIC90,nM,,50000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,50.0
12093,,,22988960,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4774857,Antitubercular activity against FQ resistant Mycobacterium tuberculosis H37Rv harboring gyrA Asp-94-Gly mutant measured after 7 days by resazurin microtiter assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4765453,Eur J Med Chem,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3570387,>,1,1,>,,MIC90,nM,,50000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,50.0
12094,,,22988967,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4774858,Antitubercular activity against FQ resistant Mycobacterium tuberculosis H37Rv harboring gyrA Gly-88-Cys mutant measured after 7 days by resazurin microtiter assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4765453,Eur J Med Chem,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3570387,>,1,1,>,,MIC90,nM,,50000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,50.0
12095,,,22988974,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4774859,Antitubercular activity against FQ resistant Mycobacterium tuberculosis H37Rv harboring gyrA Ser-91-Pro mutant measured after 7 days by resazurin microtiter assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4765453,Eur J Med Chem,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3570387,>,1,1,>,,MIC90,nM,,50000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,50.0
12096,,,22988981,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4774860,Antitubercular activity against FQ resistant Mycobacterium tuberculosis H37Rv harboring gyrA Ala-90-Val/gyrB Glu-540-Val mutant measured after 7 days by resazurin microtiter assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4765453,Eur J Med Chem,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3570387,>,1,1,>,,MIC90,nM,,50000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,50.0
12097,,,22988988,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4774861,Antitubercular activity against FQ resistant Mycobacterium tuberculosis H37Rv harboring gyrA Asp-94-Gly/gyrB Asp-500-Asn mutant measured after 7 days by resazurin microtiter assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4765453,Eur J Med Chem,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3570387,>,1,1,>,,MIC90,nM,,50000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,50.0
12098,,Not Determined,22988995,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4774862,Antitubercular activity against Mycobacterium tuberculosis XDR measured after 7 days by resazurin microtiter assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4765453,Eur J Med Chem,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,3570387,,1,0,,,MIC90,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,,,,
12099,,,23129882,[],CHEMBL4808149,Enzymatic assay of human HDAC6 with commercial peptide substrate,B,,,BAO_0000201,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4808148,,2021.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,3594391,=,59,1,=,,Inhibition,%,,-37.85,CHEMBL1865,Homo sapiens,Histone deacetylase 6,9606.0,,,inhibition,%,UO_0000187,,-37.85
12100,,,23138666,[],CHEMBL4808150,Enzymatic assay of human HDAC6 with custom peptide substrate,B,,,BAO_0000201,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4808148,,2021.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,3594391,=,59,1,=,,Inhibition,%,,1.43,CHEMBL1865,Homo sapiens,Histone deacetylase 6,9606.0,,,inhibition,%,UO_0000187,,1.43
12101,"{'action_type': 'STABILISER', 'description': 'Increases the conformational stability of a protein or complex', 'parent_type': 'OTHER'}",,23262871,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '400.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '400.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL4833456,Inhibition of 8-anilinonaphthalene-l-sulfonic acid binding to TTR V3OM mutant (unknown origin) expressed in Escherichia coli assessed as ANS saturation ratio at 400 uM incubated for 1 hr in presence of 7.5 uM ANS by fluorescence method (Rvb = 56 +/- 2.3%),B,P02766,V50M,BAO_0001103,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4831538,J Med Chem,2021.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,3619123,=,1,0,=,,Activity,%,,53.0,CHEMBL3194,Homo sapiens,Transthyretin,9606.0,,,Activity,%,UO_0000187,,53.0
12102,"{'action_type': 'STABILISER', 'description': 'Increases the conformational stability of a protein or complex', 'parent_type': 'OTHER'}",,23262914,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '400.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '400.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL4833457,Inhibition of 8-anilinonaphthalene-l-sulfonic acid binding to TTR V3OM mutant (unknown origin) expressed in Escherichia coli at 400 uM incubated for 1 hr in presence of 75 uM ANS by fluorescence method (Rvb = 91 +/- 0.92%),B,P02766,V50M,BAO_0001103,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4831538,J Med Chem,2021.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,3619123,=,1,0,=,,Activity,%,,88.0,CHEMBL3194,Homo sapiens,Transthyretin,9606.0,,,Activity,%,UO_0000187,,88.0
12103,,,23262967,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '4.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '4.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'weeks', 'value': '1.0'}]",CHEMBL4833459,Stabilization of TTR V3OM mutant (unknown origin) assessed as acid-mediated protein aggregation inhibition ratio at 4 uM incubated for 1 week by absorbance method,B,P02766,V50M,BAO_0001103,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4831538,J Med Chem,2021.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,3619123,=,1,0,=,,Activity,%,,7.4,CHEMBL3194,Homo sapiens,Transthyretin,9606.0,,,Activity,%,UO_0000187,,7.4
12104,,,23263010,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'weeks', 'value': '1.0'}]",CHEMBL4833460,Stabilization of TTR V3OM mutant (unknown origin) assessed as acid-mediated protein aggregation inhibition ratio at 10 uM incubated for 1 week by absorbance method,B,P02766,V50M,BAO_0001103,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL4831538,J Med Chem,2021.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://qudt.org/vocab/unit#Percent,3619123,=,1,0,=,,Activity,%,,-4.3,CHEMBL3194,Homo sapiens,Transthyretin,9606.0,,,Activity,%,UO_0000187,,-4.3
12105,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24813526,[],CHEMBL5137765,"Inhibition of PKM2 (unknown origin) Ile51, Asn75, Ser77, Asp177, Hie78, Lys367 residues",B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5136976,J Med Chem,2022.0,"{'bei': '18.41', 'le': '0.34', 'lle': '2.86', 'sei': '5.92'}",CHEMBL5,NALIDIXIC ACID,CHEMBL5,4.28,1,http://www.openphacts.org/units/Nanomolar,3874160,=,1,1,=,,IC50,nM,,53000.0,CHEMBL1075189,Homo sapiens,Pyruvate kinase isozymes M1/M2,9606.0,,,IC50,uM,UO_0000065,,53.0
12106,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24971739,[],CHEMBL5223207,Inhibition of PKM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5223062,RSC Med Chem,2021.0,"{'bei': '18.41', 'le': '0.34', 'lle': '2.86', 'sei': '5.92'}",CHEMBL5,NALIDIXIC ACID,CHEMBL5,4.28,0,http://www.openphacts.org/units/Nanomolar,3902063,=,1,1,=,,IC50,nM,,53000.0,CHEMBL1075189,Homo sapiens,Pyruvate kinase isozymes M1/M2,9606.0,,,IC50,uM,UO_0000065,,53.0
12107,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25005077,[],CHEMBL5234501,Inhibition of Escherichia coli DNA gyrase,B,,,BAO_0000190,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,1,http://www.openphacts.org/units/MicrogramPerMilliliter,3912693,=,1,1,=,,IC50,ug.mL-1,,1.74,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,ug ml-1,UO_0000274,,1.74
12108,,,25005134,[],CHEMBL5234518,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3912693,=,1,1,=,,IC50,ug.mL-1,,47.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IC50,ug ml-1,UO_0000274,,47.0
12109,,,25005137,[],CHEMBL5234519,Antibacterial activity against methicillin-sensitive Staphylococcus aureus,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3912693,=,1,1,=,,IC50,ug.mL-1,,47.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IC50,ug ml-1,UO_0000274,,47.0
12110,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25005143,[],CHEMBL5234520,Inhibition of Staphylococcus aureus DNA gyrase,B,,,BAO_0000190,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233247,Eur J Med Chem,2020.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3912693,=,1,1,=,,IC50,nM,,800000.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,uM,UO_0000065,,800.0
12111,,,25040085,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5244529,Antimalarial activity against hepatic stage Plasmodium yoelii yoelii 265 BY for 48 hrs with media renew every 24 hrs,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922443,>,1,1,>,,IC50,ug.mL-1,,100.0,CHEMBL612328,Plasmodium yoelii yoelii,Plasmodium yoelii yoelii,73239.0,,,IC50,ug ml-1,UO_0000274,,100.0
12112,,,25040110,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '96.0'}]",CHEMBL5244530,Antimalarial activity against blood stage chloroquine-sensitive Plasmodium falciparum NF54-R infected in erythrocytes assessed as reduction in parasite growth preincubated for 72 hrs followed by addition of [3H]Hypoxanthine and measured after 24 hrs by liquid scintillation counting method,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922443,=,1,1,=,,IC50,ug.mL-1,,59.1,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,ug ml-1,UO_0000274,,59.1
12113,,,25040136,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '96.0'}]",CHEMBL5244531,Antimalarial activity against blood stage chloroquine-sensitive Plasmodium falciparum 3D7 infected in erythrocytes assessed as reduction in parasite growth preincubated for 72 hrs followed by addition of [3H]Hypoxanthine and measured after 24 hrs by liquid scintillation counting method,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922443,=,1,1,=,,IC50,ug.mL-1,,116.6,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,ug ml-1,UO_0000274,,116.6
12114,,,25040206,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5244554,Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human erythrocyte incubated for 72 hrs by SYBR green I staining based fluorescence assay,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3922443,>,1,1,>,,IC50,nM,,20000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,nM,UO_0000065,,20000.0
12115,,,25041029,[],CHEMBL5244840,Antibacterial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3922892,=,1,1,=,,MIC,nM,,4300000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,4.3
12116,,,25078263,[],CHEMBL5255088,"Acidic ionization constant, pKa of the compound in water by potentiometric titration method",P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5252580,Bioorg Med Chem,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,3931127,=,1,0,=,,pKa,,,6.25,CHEMBL2362975,,No relevant target,,,,pKa,,,,6.25
12117,,,25078275,[],CHEMBL5255090,"Ionization constant, pKa of the compound in water in presence of 20 to 27.4% acetonitrile cosolvent by potentiometric titration method",P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5252580,Bioorg Med Chem,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,3931127,=,1,0,=,,pKa,,,6.63,CHEMBL2362975,,No relevant target,,,,pKa,,,,6.63
12118,,,25078286,[],CHEMBL5255091,"Ionization constant, pKa of the compound in water in presence of 30 to 35% acetonitrile cosolvent by potentiometric titration method",P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5252580,Bioorg Med Chem,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,3931127,=,1,0,=,,pKa,,,7.1,CHEMBL2362975,,No relevant target,,,,pKa,,,,7.1
12119,,,25078297,[],CHEMBL5255092,"Ionization constant, pKa of the compound in water in presence of 40 to 42.6% acetonitrile cosolvent by potentiometric titration method",P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5252580,Bioorg Med Chem,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,3931127,=,1,0,=,,pKa,,,7.56,CHEMBL2362975,,No relevant target,,,,pKa,,,,7.56
12120,,,25078304,[],CHEMBL5255093,"Basic ionization constant, pKa of the compound in 100% acetonitrile by UV-vis spectrophotometric titration method",P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5252580,Bioorg Med Chem,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,3931127,=,1,0,=,,pKa,,,6.17,CHEMBL612545,,Unchecked,,,,pKa,,,,6.17
12121,,Not Determined,25078315,[],CHEMBL5255094,"Ionization constant, pKa of the compound in water in presence of 80% acetonitrile cosolvent by PLRP-S based RP-HPLC analysis",P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5252580,Bioorg Med Chem,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,3931127,,1,0,,,pKa,,,,CHEMBL2362975,,No relevant target,,,,pKa,,,,
12122,,,25078321,[],CHEMBL5255095,"Acidic ionization constant, pKa of the compound in 100% acetonitrile by UV-vis spectrophotometric titration method",P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5252580,Bioorg Med Chem,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,3931127,=,1,0,=,,pKa,,,26.44,CHEMBL2362975,,No relevant target,,,,pKa,,,,26.44
12123,,Not Determined,25078332,[],CHEMBL5255096,"Lipophilicity, log P of the compound in octanol/water system by potentiometric titration method",P,,,BAO_0002130,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5252580,Bioorg Med Chem,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,3931127,,1,0,,,LogP,,,,CHEMBL2362975,,No relevant target,,,,logP,,,,
12124,,Not Determined,25078343,[],CHEMBL5255097,"Lipophilicity, log D of the compound in octanol/water system at pH 7 by potentiometric titration method",P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5252580,Bioorg Med Chem,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,3931127,,1,0,,,LogD,,,,CHEMBL2362975,,No relevant target,,,,logD,,,,
12125,,,25078354,[],CHEMBL5255098,"Lipophilicity, log D of the compound in octanol/water system at pH 7 by shake-flask assay based HPLC analysis",P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5252580,Bioorg Med Chem,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,3931127,=,1,1,=,,LogD,,,0.35,CHEMBL2362975,,No relevant target,,,,logD,,,,0.35
12126,,Not Determined,25078364,[],CHEMBL5255099,"Lipophilicity, log P of the compound in toluene/water system by potentiometric titration method",P,,,BAO_0002130,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5252580,Bioorg Med Chem,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,3931127,,1,0,,,LogP,,,,CHEMBL2362975,,No relevant target,,,,logP,,,,
12127,,Not Determined,25078374,[],CHEMBL5255100,"Lipophilicity, log D of the compound in toluene/water system at pH 7 by potentiometric titration method",P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5252580,Bioorg Med Chem,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,3931127,,1,0,,,LogD,,,,CHEMBL2362975,,No relevant target,,,,logD,,,,
12128,,,25078385,[],CHEMBL5255101,"Lipophilicity, log D of the compound in toluene/water system at pH 7 by shake-flask assay based HPLC analysis",P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5252580,Bioorg Med Chem,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,3931127,=,1,1,=,,LogD,,,-0.12,CHEMBL2362975,,No relevant target,,,,logD,,,,-0.12
12129,,,25078396,[],CHEMBL5255102,"Lipophilicity, log D of the compound assessed as retention index in nonpolar system in presence of 80% acetonitrile cosolvent by PLRP-S based RP-HPLC analysis",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5252580,Bioorg Med Chem,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,,3931127,=,1,0,=,,Retention_index,,,-0.15,CHEMBL2362975,,No relevant target,,,,Retention_index,,,,-0.15
12130,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25115350,[],CHEMBL5291779,Binding affinity towards human DRD1 in an in vitro assay with cellular components (NIBR assay) measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
12131,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25117891,[],CHEMBL5291828,"Compound was evaluated for inhibition of human KCNH2 in an in vitro assay with cellular components measured by membrane filtration, radioactivity method",F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL240,Homo sapiens,HERG,9606.0,,,AC50,uM,UO_0000065,,30.0
12132,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25125099,[],CHEMBL5291882,Binding affinity towards human SLC6A3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
12133,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25138998,[],CHEMBL5291792,Binding affinity towards human ESR1 in an in vitro cell free assay (CRO assay) measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,AC50,uM,UO_0000065,,30.0
12134,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25142688,[],CHEMBL5291723,Compound was evaluated for inhibition of human ACHE in an vitro cell free assay measured by absorbance method,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,AC50,uM,UO_0000065,,30.0
12135,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25146140,[],CHEMBL5291881,Binding affinity towards human SLC6A2 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
12136,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25151467,[],CHEMBL5291883,Binding affinity towards human SLC6A4 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
12137,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25156569,[],CHEMBL5291736,Binding affinity towards human ADRA2A in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
12138,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25158315,[],CHEMBL5291855,Binding affinity towards human OPRM1 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
12139,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25160831,[],CHEMBL5291830,Compound was evaluated for inhibition of human MAOA in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,AC50,uM,UO_0000065,,30.0
12140,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25165164,[],CHEMBL5291815,Binding affinity towards human HTR1A in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
12141,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25168336,[],CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL279,Homo sapiens,Vascular endothelial growth factor receptor 2,9606.0,,,AC50,uM,UO_0000065,,30.0
12142,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25191857,[],CHEMBL5291856,Compound was evaluated for inhibition of human PDE3A in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL241,Homo sapiens,Phosphodiesterase 3A,9606.0,,,AC50,uM,UO_0000065,,30.0
12143,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25194660,[],CHEMBL5291782,Binding affinity towards human DRD3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
12144,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25195876,[],CHEMBL5291766,Binding affinity towards human CHRM2 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,30.0
12145,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25196846,[],CHEMBL5291794,Compound was evaluated for inhibition of human F2 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL204,Homo sapiens,Thrombin,9606.0,,,AC50,uM,UO_0000065,,30.0
12146,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25197993,[],CHEMBL5291888,Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2069,Homo sapiens,Thromboxane A2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
12147,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25198833,[],CHEMBL5291728,Binding affinity towards human ADORA3 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
12148,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25199672,[],CHEMBL5291812,Binding affinity towards human HRH3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL264,Homo sapiens,Histamine H3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
12149,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25201605,[],CHEMBL5291820,Agonist activity at human HTR2B in an in vitro cell-based assay (CRO assay) measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
12150,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25202818,[],CHEMBL5291799,Binding affinity towards human GABRA1 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL5303741,Homo sapiens,Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2,9606.0,,,AC50,uM,UO_0000065,,30.0
12151,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25203498,[],CHEMBL5291749,Binding affinity towards human AR in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1871,Homo sapiens,Androgen Receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
12152,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25204431,[],CHEMBL5291863,Binding affinity towards human PGR in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL208,Homo sapiens,Progesterone receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
12153,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25205364,[],CHEMBL5291869,Compound was evaluated for inhibition of human PTGS1 in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,5.14,0,http://www.openphacts.org/units/Nanomolar,3940757,=,1,1,=,,AC50,nM,,7267.8,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,AC50,uM,UO_0000065,,7.2678
12154,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25206295,[],CHEMBL5291871,Compound was evaluated for inhibition of human PTGS1 in an in vitro cell free assay measured by fluorescence method,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,AC50,uM,UO_0000065,,30.0
12155,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25207227,[],CHEMBL5291857,Compound was evaluated for inhibition of human PDE4A in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL254,Homo sapiens,Phosphodiesterase 4A,9606.0,,,AC50,uM,UO_0000065,,30.0
12156,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25208658,[],CHEMBL5291730,Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
12157,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25209505,[],CHEMBL5291759,Agonist activity at human CHRM1 in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,30.0
12158,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25210333,[],CHEMBL5291761,Antagonist activity human CHRM1 in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,30.0
12159,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25211234,[],CHEMBL5291887,Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2069,Homo sapiens,Thromboxane A2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
12160,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25218970,[],CHEMBL5291731,Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5,NALIDIXIC ACID,CHEMBL5,,0,http://www.openphacts.org/units/Nanomolar,3940757,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
12161,,,55330,[],CHEMBL688000,Lowest concentration necessary to induce DNA gyrase-mediated cleavage of DNA,B,,,BAO_0002752,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,222,=,1,0,=,,Concentration,ug ml-1,,1.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,Concentration,ug ml-1,UO_0000274,,1.0
12162,,,55331,[],CHEMBL689081,Concentration required for 50% inhibition of gyrase.,B,,,BAO_0002752,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,222,=,1,0,=,,Concentration,ug ml-1,,5.5,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,Concentration,ug ml-1,UO_0000274,,5.5
12163,,,55332,[],CHEMBL677348,Minimum inhibitory concentration against Escherichia coli (H560),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,222,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.1
12164,,,55333,[],CHEMBL677349,Minimum inhibitory concentration against Escherichia coli (vogel),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,222,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
12165,,,55334,[],CHEMBL700973,Minimum inhibitory concentration against Klebsiella pneumoniae (MGH-2),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,222,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
12166,,,55335,[],CHEMBL772086,Minimum inhibitory concentration against Providencia rettgeri. (M1771),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,222,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC,ug ml-1,UO_0000274,,0.05
12167,,,55336,[],CHEMBL682405,Minimum inhibitory concentration against Enterobacter cloacae. (MA2446).,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,222,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.1
12168,,,55337,[],CHEMBL763460,Minimum inhibitory concentration against Pseudomonas aeruginosa. (UI-18),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,222,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
12169,,,55338,[],CHEMBL809590,Minimum inhibitory concentration against Staphylococcus aureus (H-228).,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,222,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.8
12170,,,55339,[],CHEMBL810411,Minimum inhibitory concentration against Staphylococcus aureus (UC76).,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,222,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
12171,,,55340,[],CHEMBL882117,Minimum inhibitory concentration against Streptococcus faecalis (MGH-2).,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,222,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.6
12172,,,55341,[],CHEMBL811346,Minimum inhibitory concentration against Streptococcus pneumoniae (SV-1).,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,222,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.6
12173,,,55342,[],CHEMBL809189,Minimum inhibitory concentration against Streptococcus pyogenes (C203).,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,222,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.8
12174,,,55343,[],CHEMBL823200,Minimum inhibitory concentration as geometric mean calculated for the gram-negative enterobacteriaceae.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,222,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614439,Enterobacter,Enterobacter,547.0,,,MIC,ug ml-1,UO_0000274,,0.06
12175,,,55344,[],CHEMBL742309,In vivo activity against Escherichia coli (po),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,222,=,1,0,=,,PD50,mg kg-1,,4.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,4.0
12176,,,55345,[],CHEMBL857253,In vivo activity against Escherichia coli (sc),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,222,=,1,0,=,,PD50,mg kg-1,,0.6,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,0.6
12177,,,55346,[],CHEMBL738927,In vivo activity against Pseudomonas aeruginosa (po),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,222,=,1,0,=,,PD50,mg kg-1,,76.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,76.0
12178,,,55347,[],CHEMBL738928,In vivo activity against Pseudomonas aeruginosa (sc),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,222,=,1,0,=,,PD50,mg kg-1,,11.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,11.0
12179,,,55348,[],CHEMBL738931,In vivo activity against Streptococcus pyogenes (po),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,222,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,100.0
12180,,,55349,[],CHEMBL738932,In vivo activity against Streptococcus pyogenes (sc),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,222,=,1,0,=,,PD50,mg kg-1,,45.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,45.0
12181,,,55350,[],CHEMBL738929,In vivo activity against Streptococcus pneumoniae (po),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,222,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,100.0
12182,,,55351,[],CHEMBL738930,In vivo activity against Streptococcus pneumoniae (sc),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,222,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,100.0
12183,,,61685,[],CHEMBL873322,Antibacterial activity against Klebsiella ozaenae,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0381,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.0381
12184,,,61686,[],CHEMBL700135,Antibacterial activity against Klebsiella pneumoniae,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0381,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.0381
12185,,,61687,[],CHEMBL802305,Antibacterial activity against Shigella sonnei,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0381,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,,MIC,ug ml-1,UO_0000274,,0.0381
12186,,,61688,[],CHEMBL804813,Antibacterial activity against Shigella boydii,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0381,CHEMBL614395,Shigella boydii,Shigella boydii,621.0,,,MIC,ug ml-1,UO_0000274,,0.0381
12187,,,61689,[],CHEMBL766966,Antibacterial activity against Plesiomonas shigelloides,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0763,CHEMBL614405,Plesiomonas shigelloides,Plesiomonas shigelloides,703.0,,,MIC,ug ml-1,UO_0000274,,0.0763
12188,,,61690,[],CHEMBL879669,Antibacterial activity against Morganella morganii,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0763,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.0763
12189,,,61691,[],CHEMBL809474,Antibacterial activity against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.1526,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.1526
12190,,,61692,[],CHEMBL770155,Antibacterial activity against Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0763,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.0763
12191,,,61693,[],CHEMBL813506,Antibacterial activity against Vibrio mimicus,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.1526,CHEMBL612621,Vibrio mimicus,Vibrio mimicus,674.0,,,MIC,ug ml-1,UO_0000274,,0.1526
12192,,,61694,[],CHEMBL813499,Antibacterial activity against Vibrio fluvialis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0763,CHEMBL614602,Vibrio fluvialis,Vibrio fluvialis,676.0,,,MIC,ug ml-1,UO_0000274,,0.0763
12193,,,61695,[],CHEMBL816175,Antibacterial activity against Vibrio cholerae 0139,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0763,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,0.0763
12194,,,61696,[],CHEMBL816174,Antibacterial activity against Vibrio cholerae 01,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0763,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,0.0763
12195,,,61697,[],CHEMBL813512,Antibacterial activity against Vibrio parahaemolyticus,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0763,CHEMBL614403,Vibrio parahaemolyticus,Vibrio parahaemolyticus,670.0,,,MIC,ug ml-1,UO_0000274,,0.0763
12196,,,61698,[],CHEMBL674714,Antibacterial activity against Escherichia coli NCTC 10418,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0381,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.0381
12197,,,61699,[],CHEMBL675405,Antibacterial activity against Edwardsiella tarda,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0381,CHEMBL614598,Edwardsiella tarda,Edwardsiella tarda,636.0,,,MIC,ug ml-1,UO_0000274,,0.0381
12198,,,61700,[],CHEMBL857812,Antibacterial activity against Proteus vulgaris,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0381,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.0381
12199,,,61701,[],CHEMBL765014,Antibacterial activity against Proteus mirabilis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0763,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.0763
12200,,,61702,[],CHEMBL803305,Antibacterial activity against Salmonella Typhimurium,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0763,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.0763
12201,,,61703,[],CHEMBL801481,Antibacterial activity against Salmonella paratyphi A,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0381,CHEMBL612293,Salmonella enterica subsp. enterica serovar Paratyphi A,Salmonella paratyphi,54388.0,,,MIC,ug ml-1,UO_0000274,,0.0381
12202,,,61704,[],CHEMBL799645,Antibacterial activity against Klebsiella ozaenae Salmonella typhi,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0763,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,0.0763
12203,,,61705,[],CHEMBL803218,Antibacterial activity against Salmonella enteritidis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0381,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,,MIC,ug ml-1,UO_0000274,,0.0381
12204,,,61706,[],CHEMBL657688,Antibacterial activity against Citrobacter ferundii,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0381,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC,ug ml-1,UO_0000274,,0.0381
12205,,,61707,[],CHEMBL679746,Antibacterial activity against Enterobacter,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0763,CHEMBL614439,Enterobacter,Enterobacter,547.0,,,MIC,ug ml-1,UO_0000274,,0.0763
12206,,,61708,[],CHEMBL649198,Antibacterial activity against Bacillus megatherium,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350596,=,1,1,=,,MIC,ug.mL-1,,0.0763,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,,MIC,ug ml-1,UO_0000274,,0.0763
12207,,,67443,[],CHEMBL702885,Binding constant against human serum albumin (HSA),B,,,BAO_0000179,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134302,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,264466,=,1,0,=,,Log K',,,0.14,CHEMBL3253,Homo sapiens,Serum albumin,9606.0,,,Log K',,,,0.14
12208,,,70207,[],CHEMBL679318,Minimum inhibitory concentration against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1132978,J Med Chem,2000.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16193,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.1
12209,,,92967,[],CHEMBL813809,Minimum inhibitory concentration (MIC) against Staphylococcus aureus 1199B; Range 50 - 6.3 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146781,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,196284,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,50.0
12210,,,92968,[],CHEMBL813811,Minimum inhibitory concentration (MIC) against Staphylococcus aureus K2068; Range 12.5 1.6 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146781,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,196284,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,12.5
12211,,,98923,[],CHEMBL662294,Mammalian cell cytotoxicity test in chinese hamster V79 cells (clonogenic cytotoxicity),F,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1125556,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,278240,>,1,1,>,,IC50,ug.mL-1,,500.0,CHEMBL614074,Cricetulus griseus,V79,10029.0,,,IC50,ug ml-1,UO_0000274,,500.0
12212,,,98924,[],CHEMBL682682,Antibacterial activity against five Gram-negative bacteria,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125556,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,278240,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.06
12213,,,98925,[],CHEMBL682431,Antibacterial activity against five Gram-positive bacteria targeting topoisomerase II (DNA gyrase B GyrB),F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125556,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,278240,=,1,1,=,,MIC,ug.mL-1,,0.61,CHEMBL1921666,Staphylococcus aureus,DNA gyrase subunit B,1280.0,,,MIC,ug ml-1,UO_0000274,,0.61
12214,,,101546,[],CHEMBL806924,Minimum Inhibitory concentration measured against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1128580,J Med Chem,1995.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,153222,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
12215,,,101547,[],CHEMBL812354,Minimum Inhibitory concentration measured against Streptococcus faecalis ATCC 29212,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1128580,J Med Chem,1995.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,153222,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
12216,,,101548,[],CHEMBL809201,Minimum Inhibitory concentration measured against Streptococcus pyogenes ATCC 6301,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1128580,J Med Chem,1995.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,153222,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,4.0
12217,,,101549,[],CHEMBL678958,Minimum Inhibitory concentration measured against Escherichia coli ATCC 1-25922,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1128580,J Med Chem,1995.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,153222,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
12218,,,101550,[],CHEMBL762961,Minimum Inhibitory concentration measured against Pseudomonas aeruginosa ATCC 27853,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1128580,J Med Chem,1995.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,153222,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
12219,,,101551,[],CHEMBL651947,Minimum Inhibitory concentration measured against Bacteroides fragilis ATCC 25285,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1128580,J Med Chem,1995.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,153222,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,8.0
12220,,,125334,[],CHEMBL808936,The compound was tested in vitro for antibiotic activity against Staphylococcus aureus ATCC 6538P,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123550,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,60706,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
12221,,,125335,[],CHEMBL808935,The compound was tested in vitro for antibiotic activity against Staphylococcus aureus 686B,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123550,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,60706,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
12222,,,125336,[],CHEMBL806198,The compound was tested in vitro for antibiotic activity against Staphylococcus epidermidis 3519,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123550,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,60706,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.56
12223,,,125337,[],CHEMBL811551,The compound was tested in vitro for antibiotic activity against Staphylococcus faecium ATCC 8043,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123550,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,60706,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.78
12224,,,125338,[],CHEMBL806304,The compound was tested in vitro for antibiotic activity against Staphylococcus pyogenes 930,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123550,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,60706,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,3.1
12225,,,125339,[],CHEMBL676858,Compound was tested in vitro for antibiotic activity against the bacteria Escherichia coli juhl,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123550,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,60706,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.1
12226,,,125340,[],CHEMBL679090,Compound was tested in vitro for antibiotic activity against bacteria Enterobacter aerogenes ATCC 13048,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123550,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,60706,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.2
12227,,,125341,[],CHEMBL701609,Compound was tested in vitro for antibiotic activity against the bacteria Klebsiella pneumoniae 8045,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123550,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,60706,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.1
12228,,,125342,[],CHEMBL764766,Compound was tested in vitro for antibiotic activity against the bacteria Pseudomonas aeruginosa 5007,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123550,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,60706,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.39
12229,,,125343,[],CHEMBL764937,Compound was tested in vitro for antibiotic activity against the bacteria Pseudomonas aeruginosa K799/WT,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123550,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,60706,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.39
12230,,,125344,[],CHEMBL644942,Compound was tested in vitro for antibiotic activity against the bacteria Acinetobacter sp. CMX669,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123550,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,60706,=,1,1,=,,MIC,ug.mL-1,,6.2,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,,MIC,ug ml-1,UO_0000274,,6.2
12231,,,171166,[],CHEMBL798727,In vitro antibacterial activity against Staphylococcus aureus Smith (A9537),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,295214,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
12232,,,171167,[],CHEMBL671304,In vitro antibacterial activity against Escherichia coli (A 15119),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,295214,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.13
12233,,,171168,[],CHEMBL702897,In vitro antibacterial activity against Klebsiella pneumoniae (A 9664),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,295214,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
12234,,,171169,[],CHEMBL674190,In vitro antibacterial activity against Enterobacter cloacae (A 9656),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,295214,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.06
12235,,,171170,[],CHEMBL706441,In vitro antibacterial activity against Morganella morganii (A 15153),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,295214,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.015
12236,,,171171,[],CHEMBL754842,In vitro antibacterial activity against Pseudomonas aeruginosa (A 9843),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,295214,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
12237,,,171172,[],CHEMBL798728,In vivo efficacy in systemic infection due to Staphylococcus aureus Smith (A 9537) in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,295214,=,1,0,=,,PD50,mg kg-1,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PD50,mg kg-1,UO_0000308,,10.0
12238,,,171173,[],CHEMBL754843,In vivo efficacy in systemic infection due to Pseudomonas aeruginosa (A 9843) in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,295214,=,1,0,=,,PD50,mg kg-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,PD50,mg kg-1,UO_0000308,,16.0
12239,,,171174,[],CHEMBL671305,In vivo efficacy in systemic infection due to Escherichia coli (A 15119) in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,295214,=,1,0,=,,PD50,mg kg-1,,3.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,3.0
12240,,,171175,[],CHEMBL705172,In vivo efficacy in systemic infection due to Klebsiella pneumoniae (A 9664) in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,295214,=,1,0,=,,PD50,mg kg-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,PD50,mg kg-1,UO_0000308,,8.0
12241,,,171176,[],CHEMBL727606,Lethal dose of compound in OF1-strain female swiss mice after oral administration,T,,,BAO_0002117,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124630,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,295214,>,1,1,>,,LD50,mg.kg-1,,2500.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,LD50,mg kg-1,UO_0000308,,2500.0
12242,,,181903,[],CHEMBL674214,Inhibitory activity against ATCC 13048 strain(Enterobacter aerogenes) in the presence of Norfloxacin and fluoroquinolone at 16 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134275,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,248781,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.05
12243,,,181904,[],CHEMBL674216,Inhibitory activity against ATCC 13048 strain(Enterobacter aerogenes) in the presence of ciprofloxacin fluoroquinolone at 16 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134275,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,248781,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,2.0
12244,,,181905,[],CHEMBL674221,Inhibitory activity against p9- (derivative of ATCC )13048 strain(Enterobacter aerogenes) in the presence of Norfloxacin and fluoroquinolone at 16 ug/mL,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134275,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,248781,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,128.0
12245,,,193684,[],CHEMBL672107,"Antibacterial activity against gram negative organism, Escherichia cloacae (MA2646)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18081,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.1
12246,,,193685,[],CHEMBL674333,"Antibacterial activity was determined against gram negative organism, E. coli(vogel)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18081,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
12247,,,193686,[],CHEMBL706025,"Antibacterial activity was determined against gram negative organism, K. pneumoniae (MGH-2)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18081,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
12248,,,193687,[],CHEMBL755846,"Antibacterial activity was determined against gram negative organism, Providencia rettgeri. (M1771)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18081,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL612490,Bacteria,Bacteria,2.0,,,MIC,ug ml-1,UO_0000274,,0.025
12249,,,193688,[],CHEMBL755262,"Antibacterial activity was determined against gram negative organism, Pseudomonas aeruginosa (UI-18)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18081,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
12250,,,193689,[],CHEMBL805136,"Antibacterial activity was determined against gram positive organism, Staphylococcus aureus (H228)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18081,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.8
12251,,,193690,[],CHEMBL805137,"Antibacterial activity was determined against gram positive organism, Staphylococcus aureus (UC76)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18081,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
12252,,,193691,[],CHEMBL799852,"Antibacterial activity was determined against gram positive organism, Streptococcus faecalis (MGH-2)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18081,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.6
12253,,,193692,[],CHEMBL799744,"Antibacterial activity was determined against gram positive organism, Streptococcus pneumoniae (SV-1)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18081,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.6
12254,,,193693,[],CHEMBL801924,"Antibacterial activity was determined against gram positive organism, Streptococcus pyogenes (C203)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18081,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.8
12255,,,193694,[],CHEMBL875406,Minimum inhibitory concentration required to inhibit DNA gyrase supercoiling.,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,18081,=,1,0,=,,DNA cleavage,ug ml-1,,1.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,DNA cleavage,ug ml-1,UO_0000274,,1.0
12256,,,193695,[],CHEMBL847744,MIC ratio measured as the mean MICs of gram-negative bacteria,F,,,BAO_0000193,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,18081,=,1,0,=,,Ratio,,,0.057,CHEMBL612545,,Unchecked,,,,Ratio,,,,0.057
12257,,,193696,[],CHEMBL847746,MIC ratio measured as the mean MICs of gram-positive bacteria,F,,,BAO_0000193,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125920,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,18081,=,1,0,=,,Ratio,,,0.61,CHEMBL612545,,Unchecked,,,,Ratio,,,,0.61
12258,,,235518,[],CHEMBL809613,Compound was tested for antimicrobial activity against Staphylococcus aureus FDA207PJC-1,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Activity,,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,0.39
12259,,,235519,[],CHEMBL650277,Compound was tested for antimicrobial activity against Bacillus subtilis ATCC 6633,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Activity,,,0.39,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,Activity,,,,0.39
12260,,,235520,[],CHEMBL675424,Compound was tested for antimicrobial activity against Escherichia coli KC-14,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Activity,,,0.39,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,0.39
12261,,,235521,[],CHEMBL704189,Compound was tested for antimicrobial activity against Klebsiella pneumonia IFO3512,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Activity,,,0.2,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,,,,0.2
12262,,,235522,[],CHEMBL805913,Compound was tested for antimicrobial activity against Serratia marcescens 16,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Activity,,,0.78,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Activity,,,,0.78
12263,,,235523,[],CHEMBL764029,Compound was tested for antimicrobial activity against Proteus vulgaris OX-19,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Activity,,,0.2,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,Activity,,,,0.2
12264,,,235524,[],CHEMBL764786,Compound was tested for antimicrobial activity against Pseudomonas aeruginosa PAO1,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Activity,,,0.78,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,0.78
12265,,,235525,[],CHEMBL673426,Compound was tested for antimicrobial activity in mice infected with Escherichia coli KC-14 after peroral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,1,=,,ED50,mg.kg-1,,4.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,4.38
12266,,,235526,[],CHEMBL723509,"Serum concentration in mice, after oral administration at a dose of 100 mg/kg p.o. at 0.5 h",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Serum concentration,,,3.47,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,3.47
12267,,,235527,[],CHEMBL723510,"Serum concentration in mice, after oral administration at a dose of 100 mg/kg p.o. at 1 hr",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Serum concentration,,,2.02,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,2.02
12268,,,235528,[],CHEMBL723511,"Serum concentration in mice, after oral administration at a dose of 100 mg/kg p.o. at 2 hr",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Serum concentration,,,1.12,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,1.12
12269,,,235529,[],CHEMBL723512,"Serum concentration in mice, after oral administration at a dose of 100 mg/kg p.o. at 5 hr",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Serum concentration,,,0.56,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,0.56
12270,,,235530,[],CHEMBL723509,"Serum concentration in mice, after oral administration at a dose of 100 mg/kg p.o. at 0.5 h",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Serum concentration,,,6.33,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,6.33
12271,,,235531,[],CHEMBL723510,"Serum concentration in mice, after oral administration at a dose of 100 mg/kg p.o. at 1 hr",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Serum concentration,,,5.74,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,5.74
12272,,,235532,[],CHEMBL723511,"Serum concentration in mice, after oral administration at a dose of 100 mg/kg p.o. at 2 hr",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Serum concentration,,,3.96,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,3.96
12273,,,235533,[],CHEMBL723512,"Serum concentration in mice, after oral administration at a dose of 100 mg/kg p.o. at 5 hr",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Serum concentration,,,2.62,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,2.62
12274,,,235534,[],CHEMBL723509,"Serum concentration in mice, after oral administration at a dose of 100 mg/kg p.o. at 0.5 h",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Serum concentration,,,4.69,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,4.69
12275,,,235535,[],CHEMBL723510,"Serum concentration in mice, after oral administration at a dose of 100 mg/kg p.o. at 1 hr",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Serum concentration,,,3.57,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,3.57
12276,,,235536,[],CHEMBL723511,"Serum concentration in mice, after oral administration at a dose of 100 mg/kg p.o. at 2 hr",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Serum concentration,,,1.21,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,1.21
12277,,,235537,[],CHEMBL723512,"Serum concentration in mice, after oral administration at a dose of 100 mg/kg p.o. at 5 hr",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Serum concentration,,,0.49,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,0.49
12278,,,235538,[],CHEMBL723513,"Serum concentration in mice, after oral administration at a dose of 50 mg/kg p.o. at 0.5 hr",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Serum concentration,,,1.6,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,1.6
12279,,,235539,[],CHEMBL723514,"Serum concentration in mice, after oral administration at a dose of 50 mg/kg p.o. at 1 hr",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Serum concentration,,,1.6,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,1.6
12280,,,235540,[],CHEMBL723515,"Serum concentration in mice, after oral administration at a dose of 50 mg/kg p.o. at 2 hr",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Serum concentration,,,0.72,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,0.72
12281,,,235541,[],CHEMBL723516,"Serum concentration in mice, after oral administration at a dose of 50 mg/kg p.o. at 4",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Serum concentration,,,0.23,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,0.23
12282,,,235542,[],CHEMBL723513,"Serum concentration in mice, after oral administration at a dose of 50 mg/kg p.o. at 0.5 hr",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Serum concentration,,,0.45,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,0.45
12283,,,235543,[],CHEMBL723514,"Serum concentration in mice, after oral administration at a dose of 50 mg/kg p.o. at 1 hr",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Serum concentration,,,0.75,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,0.75
12284,,,235544,[],CHEMBL723515,"Serum concentration in mice, after oral administration at a dose of 50 mg/kg p.o. at 2 hr",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Serum concentration,,,0.38,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,0.38
12285,,,235545,[],CHEMBL723516,"Serum concentration in mice, after oral administration at a dose of 50 mg/kg p.o. at 4",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,Serum concentration,,,0.24,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,0.24
12286,,,235546,[],CHEMBL619440,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,A,,,BAO_0002120,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,AUC,,,6.49,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUC,,,,6.49
12287,,,235547,[],CHEMBL619442,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,A,,,BAO_0002120,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,AUC,,,3.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUC,,,,3.3
12288,,,235548,[],CHEMBL619442,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,A,,,BAO_0002120,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,AUC,,,1.9,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUC,,,,1.9
12289,,,235549,[],CHEMBL619440,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,A,,,BAO_0002120,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,AUC,,,22.01,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUC,,,,22.01
12290,,,235550,[],CHEMBL619440,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,A,,,BAO_0002120,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,0,=,,AUC,,,8.78,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUC,,,,8.78
12291,,,235551,[],CHEMBL718257,Compound was tested for antimicrobial activity in mice infected with Staphylococcus aureus smith. po,F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,1,=,,ED50,mg.kg-1,,36.4,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,36.4
12292,,,235552,[],CHEMBL718255,"Compound was tested for antimicrobial activity in mice infected with Pseudomonas aeruginosa E2,po",F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,1,=,,ED50,mg.kg-1,,59.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,59.0
12293,,,235553,[],CHEMBL787492,Lethal dose was measured in rat after iv administration,T,,,BAO_0002117,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,=,1,1,=,,LD50,mg.kg-1,,314.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,LD50,mg kg-1,UO_0000308,,314.0
12294,,,235554,[],CHEMBL787493,Lethal dose was measured in rat after oral administration,T,,,BAO_0002117,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123243,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,107304,>,1,1,>,,LD50,mg.kg-1,,4000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,LD50,mg kg-1,UO_0000308,,4000.0
12295,,,236225,[],CHEMBL681593,Antibacterial activity was evaluated against Escherichia coli,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1148326,J Med Chem,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,204626,=,1,0,=,,Log 1/C,,,6.76,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Log 1/C,,,,6.76
12296,,,236226,[],CHEMBL771945,Antibacterial activity was evaluated against Pseudomonas aeruginosa,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1148326,J Med Chem,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,204626,=,1,0,=,,Log 1/C,,,5.85,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Log 1/C,,,,5.85
12297,,,236227,[],CHEMBL810860,Antibacterial activity was evaluated against Staphylococcus aureus,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1148326,J Med Chem,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,204626,=,1,0,=,,Log 1/C,,,5.55,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Log 1/C,,,,5.55
12298,,,236228,[],CHEMBL673141,Antibacterial activity evaluated against Enterococcus faecalis,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1148326,J Med Chem,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,204626,=,1,0,=,,Log 1/C,,,5.55,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Log 1/C,,,,5.55
12299,,,240888,[],CHEMBL812454,In vitro antibacterial activity against Staphylococcus aureus ATCC 6538P,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288274,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
12300,,,240889,[],CHEMBL810887,In vitro antibacterial activity against Staphylococcus aureus CMX 686B,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288274,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
12301,,,240890,[],CHEMBL804404,In vitro antibacterial activity against Staphylococcus epidermis 3519,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288274,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.56
12302,,,240891,[],CHEMBL812911,In vitro antibacterial activity against Streptococcus faecium ATCC 8043,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288274,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.78
12303,,,240892,[],CHEMBL808966,In vitro antibacterial activity against Streptococcus pyogenes 930,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288274,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,3.1
12304,,,240893,[],CHEMBL679386,In vitro antibacterial activity against Escherichia coli Juhl,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288274,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.1
12305,,,240894,[],CHEMBL678424,In vitro antibacterial activity against Enterobacter aerogenes ATCC 13048,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288274,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.2
12306,,,240895,[],CHEMBL700095,In vitro antibacterial activity against Klebsiella pneumoniae 8045,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288274,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.1
12307,,,240896,[],CHEMBL858595,In vitro antibacterial activity against Pseudomonas aeruginosa 5007,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288274,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.39
12308,,,240897,[],CHEMBL772484,In vitro antibacterial activity against Pseudomonas aeruginosa K799/WT,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288274,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.39
12309,,,240898,[],CHEMBL857908,In vitro antibacterial activity against Acinetobacter CMX 669,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123847,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,288274,=,1,1,=,,MIC,ug.mL-1,,6.2,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,,MIC,ug ml-1,UO_0000274,,6.2
12310,,,286362,[],CHEMBL678474,Anti-bacterial activity was tested against Gram-negative EC-1 bacterium,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1129477,J Med Chem,1996.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320234,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.1
12311,,,286363,[],CHEMBL771949,Anti-bacterial activity tested against Gram-negative PA-7 bacterium,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1129477,J Med Chem,1996.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320234,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.8
12312,,,286364,[],CHEMBL807339,Anti-bacterial activity was tested against Gram-positive SA-13 bacterium,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1129477,J Med Chem,1996.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320234,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,3.1
12313,,,286365,[],CHEMBL807780,Anti-bacterial activity tested against Gram-positive SP1-1 bacterium,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1129477,J Med Chem,1996.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320234,>,1,1,>,,MIC,ug.mL-1,,3.1,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,3.1
12314,,,286366,[],CHEMBL748677,Anti-bacterial activity tested against Mycobacterium fortuitum (ATCG 6841),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1129477,J Med Chem,1996.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320234,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC,ug ml-1,UO_0000274,,0.5
12315,,,286367,[],CHEMBL752176,Anti-bacterial activity tested against Mycobacterium smegmatis (ATCG 19420),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1129477,J Med Chem,1996.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,320234,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,2.0
12316,,,286368,[],CHEMBL631421,Calculated partition coefficient (clogP),P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1129477,J Med Chem,1996.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,320234,=,1,1,=,,CLogP,,,2.21,CHEMBL2362975,,No relevant target,,,,clogP,,,,2.21
12317,,,313765,[],CHEMBL677915,Compound was tested for inhibition of the gram-negative organism Escherichia cloacae HA 2646,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268918,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.1
12318,,,313766,[],CHEMBL679368,Compound was tested for inhibition of the gram-negative organism Escherichia coli vogel,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268918,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
12319,,,313767,[],CHEMBL676379,Compound was tested for inhibition of the gram-negative organism Escherichia coli H560,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268918,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.1
12320,,,313768,[],CHEMBL705177,Compound was tested for inhibition of the gram-negative organism Klebsiella pneumoniae MGH-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268918,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
12321,,,313769,[],CHEMBL757481,Compound was tested for inhibition of the gram-negative organism Providencia rettgeri H1771,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268918,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC,ug ml-1,UO_0000274,,0.025
12322,,,313770,[],CHEMBL753897,Compound was tested for inhibition of the gram-negative organism Pseudomonas aeruginosa UI-18,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268918,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
12323,,,313771,[],CHEMBL809215,Compound was tested for inhibition of the gram-negative organism Streptococcus aureus H228.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268918,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.8
12324,,,313772,[],CHEMBL809218,Compound was tested for inhibition of the gram-negative organism Streptococcus aureus UC-76.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268918,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
12325,,,313773,[],CHEMBL812844,Compound was tested for inhibition of the gram-negative organism Streptococcus faecalis MGH-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268918,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.6
12326,,,313774,[],CHEMBL811099,Compound was tested for inhibition of the gram-negative organism Streptococcus pneumoniae SV-1,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268918,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.6
12327,,,313775,[],CHEMBL808426,Compound was tested for inhibition of the gram-negative organism Streptococcus pyogenes C203.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268918,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.8
12328,,,313776,[],CHEMBL741709,Compound was evaluated for protective dose against the Escherichia coli vogel lethal infection following peroral administration in mouse,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,268918,=,1,0,=,,PD50,mg kg-1,,4.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,4.0
12329,,,313777,[],CHEMBL742298,Compound was evaluated for protective dose against the Escherichia coli vogel lethal infection following sc administration in mouse,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,268918,=,1,0,=,,PD50,mg kg-1,,1.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,1.0
12330,,,313778,[],CHEMBL742299,Compound was evaluated for protective dose against the Streptococcus aureus UC-76 lethal infection following po administration in mouse,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,268918,=,1,0,=,,PD50,mg kg-1,,23.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,23.0
12331,,,313779,[],CHEMBL742301,Compound was evaluated for protective dose against the Streptococcus aureus UC-76 lethal infection following sc administration in mouse,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,268918,=,1,0,=,,PD50,mg kg-1,,15.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,15.0
12332,,,313780,[],CHEMBL742303,Compound was evaluated for protective dose against the Streptococcus pneumoniae SV-1 lethal infection following po administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,268918,=,1,0,=,,PD50,mg kg-1,,150.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,150.0
12333,,,313781,[],CHEMBL878067,Compound was evaluated for protective dose against Streptococcus pneumoniae SV-1 lethal infection following sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,268918,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,100.0
12334,,,313782,[],CHEMBL676841,Compound was tested for inhibition of target enzyme DNA gyrase obtained from Escherichia coli H560 cells,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123422,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,268918,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
12335,,,339269,[],CHEMBL858475,Inhibition of growth of Staphylococcus aureus (FDA207PJC-1) after incubation at 37 degree Centigrade,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123953,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,128448,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
12336,,,339270,[],CHEMBL651202,In vitro inhibition of growth of Bacillus subtilis (ATCC 6633),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123953,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,128448,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.2
12337,,,339271,[],CHEMBL677715,In vitro Inhibition of growth of Escherichia coli(KC-14),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123953,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,128448,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.1
12338,,,339272,[],CHEMBL705739,In vitro inhibition of growth of Klebsiella pneumoniae (PC-1602),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123953,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,128448,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
12339,,,339273,[],CHEMBL806504,In vitro inhibition of growth of Serratia marcescens (IAM1184),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123953,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,128448,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.2
12340,,,339274,[],CHEMBL769336,In vitro inhibition of growth of Proteus vulgaris(OX-19),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123953,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,128448,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.05
12341,,,339275,[],CHEMBL767290,In vitro inhibition of growth of Pseudomonas aeruginosa(E-2),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123953,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,128448,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.78
12342,,,339276,[],CHEMBL672397,Inhibition of growth of Escherichia coli (KC-14) upon oral administration in mice(95%CL),F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123953,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,128448,=,1,1,=,,ED50,mg.kg-1,,7.68,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,7.68
12343,,,339277,[],CHEMBL741630,Serum levels in Mice 0.5 hr after Oral administration of 50 mg/kg,A,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123953,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,128448,=,1,0,=,,Serum level,,,0.57,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum level,,,,0.57
12344,,,339278,[],CHEMBL741632,Serum levels in Mice 1 hr after Oral administration of 50 mg/kg,A,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123953,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,128448,=,1,0,=,,Serum level,,,0.44,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum level,,,,0.44
12345,,,339279,[],CHEMBL741636,Serum levels in mice 2 hr after Oral administration of 50 mg/kg,A,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123953,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,128448,=,1,0,=,,Serum level,,,0.19,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum level,,,,0.19
12346,,,339280,[],CHEMBL740705,Serum levels in mice after 4 hr Oral administration of 50 mg/kg,A,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123953,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,128448,=,1,0,=,,Serum level,,,0.08,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum level,,,,0.08
12347,,,339281,[],CHEMBL879297,Serum levels in mice after 0.5 hr Oral administration of 50 mg/kg,A,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123953,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,128448,=,1,0,=,,Serum level,,,1.13,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum level,,,,1.13
12348,,,339282,[],CHEMBL741637,Serum levels in mice after 1 hr Oral administration of 50 mg/kg,A,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123953,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,128448,=,1,0,=,,Serum level,,,0.8,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum level,,,,0.8
12349,,,339283,[],CHEMBL740704,Serum levels in mice after 2 hr Oral administration of 50 mg/kg,A,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123953,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,128448,=,1,0,=,,Serum level,,,0.3,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum level,,,,0.3
12350,,,339284,[],CHEMBL740705,Serum levels in mice after 4 hr Oral administration of 50 mg/kg,A,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123953,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,128448,=,1,0,=,,Serum level,,,0.15,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum level,,,,0.15
12351,,,339285,[],CHEMBL624488,Area under the curve in concentration/ time,A,,,BAO_0002120,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123953,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,128448,=,1,1,=,,AUC,ng.hr.mL-1,,980.0,CHEMBL612558,,ADMET,,,,AUC,ug ml-1 hr-1,,,0.9800000000000002
12352,,,339286,[],CHEMBL624488,Area under the curve in concentration/ time,A,,,BAO_0002120,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123953,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,128448,=,1,1,=,,AUC,ng.hr.mL-1,,1770.0,CHEMBL612558,,ADMET,,,,AUC,ug ml-1 hr-1,,,1.77
12353,,,367703,[],CHEMBL858511,"In vitro antibacterial activity against staphylococcus aureus FDA 209P JC-1,Sa(F)(gram-positive)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126175,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348983,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
12354,,,367704,[],CHEMBL841567,"In vitro antibacterial activity against staphylococcus aureus IID 803,(gram-positive)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126175,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348983,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.56
12355,,,367705,[],CHEMBL841570,"In vitro antibacterial activity against staphylococcus epidermidis IAM 1296, (gram-positive)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126175,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348983,=,1,1,=,,MIC,ug.mL-1,,3.13,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,3.13
12356,,,367706,[],CHEMBL675157,"In vitro antibacterial activity against Enterococcus faecalis IID 682,Ec (N),(gram-positive)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126175,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348983,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.56
12357,,,367707,[],CHEMBL675159,"In vitro antibacterial activity against Escherichia coli NIHJ JC-2,(gram-negative)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126175,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348983,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.2
12358,,,367708,[],CHEMBL674441,"In vitro antibacterial activity against Escherichia coli KC-14, Ec(K), (gram-negative)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126175,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348983,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.2
12359,,,367709,[],CHEMBL821255,"In vitro antibacterial activity against klebsiella pneumoniae B54,Kp,(gram-negative)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126175,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348983,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.1
12360,,,367710,[],CHEMBL764323,"In vitro antibacterial activity against Pseudomonas aeruginosa IFO 3445,Pa(I),(gram-negative)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126175,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348983,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.56
12361,,,367711,[],CHEMBL842297,"In vitro antibacterial activity against Pseudomonas aeruginosa E-2,Pa(E),(gram-negative)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126175,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,348983,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.56
12362,,,373823,[],CHEMBL686624,Supercoiling inhibition activity DNA gyrase isolated from Escherichia coli H560,F,,,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65571,=,1,1,=,,IC50,ug.mL-1,,1.0,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,I50,ug ml-1,UO_0000274,,1.0
12363,,,380947,[],CHEMBL676433,Compound was evaluated for in vitro antibacterial activity against gram negative organism Escherichia coli strain ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
12364,,,380948,[],CHEMBL676434,Compound was evaluated for in vitro antibacterial activity against gram negative organism Escherichia coli strain ATCC 35218,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
12365,,,380949,[],CHEMBL676435,Compound was evaluated for in vitro antibacterial activity against gram negative organism Escherichia coli strain DRCC 091,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
12366,,,380950,[],CHEMBL676436,Compound was evaluated for in vitro antibacterial activity against gram negative organism Escherichia coli strain DRCC 133,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
12367,,,380951,[],CHEMBL676437,Compound was evaluated for in vitro antibacterial activity against gram negative organism Escherichia coli strain DRCC 134,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
12368,,,380952,[],CHEMBL700148,Compound was evaluated for in vitro antibacterial activity against gram negative organism Klebsiella pneumoniae strain ATCC 10031,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
12369,,,380953,[],CHEMBL700149,Compound was evaluated for in vitro antibacterial activity against gram negative organism Klebsiella pneumoniae strain DRCC 132,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
12370,,,380954,[],CHEMBL700150,Compound was evaluated for in vitro antibacterial activity against gram negative organism Klebsiella pneumoniae strain DRCC 136,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
12371,,,380955,[],CHEMBL768289,Compound was evaluated for in vitro antibacterial activity against gram negative organism Pseudomonas fluorescence strain NCIMB 10586,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,,MIC,ug ml-1,UO_0000274,,8.0
12372,,,380956,[],CHEMBL768288,Compound was evaluated for in vitro antibacterial activity against gram negative organism Pseudomonas fluorescence strain DRCC 008,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,,MIC,ug ml-1,UO_0000274,,0.25
12373,,,380957,[],CHEMBL766460,Compound was evaluated for in vitro antibacterial activity against gram negative organism Pseudomonas aeruginosa strains ATCC 27853,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
12374,,,380958,[],CHEMBL766459,Compound was evaluated for in vitro antibacterial activity against gram negative organism Pseudomonas aeruginosa strain MTCC 1688,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
12375,,,380959,[],CHEMBL768168,Compound was evaluated for in vitro antibacterial activity against gram negative organism Pseudomonas aeruginosa strain DRCC 131,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
12376,,,380960,[],CHEMBL768340,Compound was evaluated for in vitro antibacterial activity against gram negative organism Pseudomonas aeruginosa strain DRCC 135,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
12377,,,380961,[],CHEMBL766458,Compound was evaluated for in vitro antibacterial activity against gram negative organism Pseudomonas aeruginosa strain DRCC 137,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
12378,,,380962,[],CHEMBL803174,Compound was evaluated for in vitro antibacterial activity against gram negative organism Salmonella abony strain NCIM 2257,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613765,Salmonella enterica subsp. enterica serovar Abony,Salmonella enterica subsp. enterica serovar Abony,29482.0,,,MIC,ug ml-1,UO_0000274,,0.5
12379,,,380963,[],CHEMBL799646,Compound was evaluated for in vitro antibacterial activity against gram negative organism Salmonella typhi strain MTCC 531,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,0.25
12380,,,380964,[],CHEMBL803308,Compound was evaluated for in vitro antibacterial activity against gram negative organism Salmonella Typhimurium MTCC 98,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.5
12381,,,380965,[],CHEMBL810111,Compound was evaluated for in vitro antibacterial activity against gram positive organism Staphylococcus aureus strain ATCC 6538P,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
12382,,,380966,[],CHEMBL810108,Compound was evaluated for in vitro antibacterial activity against gram positive organism Staphylococcus aureus strain ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
12383,,,380967,[],CHEMBL810109,Compound was evaluated for in vitro antibacterial activity against gram positive organism Staphylococcus aureus strain ATCC 33591,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
12384,,,380968,[],CHEMBL810110,Compound was evaluated for in vitro antibacterial activity against gram positive organism Staphylococcus aureus strain ATCC 33592,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
12385,,,380969,[],CHEMBL810113,Compound was evaluated for in vitro antibacterial activity against gram positive organism Staphylococcus aureus strain MTCC 737,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
12386,,,380970,[],CHEMBL813165,Compound was evaluated for in vitro antibacterial activity against gram positive organism Staphylococcus epidermidis strain ATCC 12228,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
12387,,,380971,[],CHEMBL813267,Compound was evaluated for in vitro antibacterial activity against gram positive organism Streptococcus faecalis strain ATCC 29212,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
12388,,,380972,[],CHEMBL813268,Compound was evaluated for in vitro antibacterial activity against gram positive organism Streptococcus faecalis strain ATCC 49384,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
12389,,,380973,[],CHEMBL813269,Compound was evaluated for in vitro antibacterial activity against gram positive organism Streptococcus faecalis strain ATCC 51299,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,2.0
12390,,,380974,[],CHEMBL882264,Compound was evaluated for in vitro antibacterial activity against gram positive organism Streptococcus pyogenes strain DRCC 092,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131559,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,292694,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,2.0
12391,,,392158,[],CHEMBL677999,Minimum inhibitory concentration (MIC) of compound was measured on Enterobacter cloacae HA 2646(gram negative organism),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123601,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,78008,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.1
12392,,,392159,[],CHEMBL678954,Minimum inhibitory concentration (MIC) of compound was measured on Escherichia coli Vogel(gram negative organism),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123601,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,78008,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
12393,,,392160,[],CHEMBL678953,Minimum inhibitory concentration (MIC) of compound was measured on Escherichia coli H560 (gram negative organism),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123601,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,78008,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.1
12394,,,392161,[],CHEMBL700395,Minimum inhibitory concentration (MIC) of compound was measured on Klebsiella pneumoniae MGH-2(gram negative organism),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123601,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,78008,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
12395,,,392162,[],CHEMBL767625,Minimum inhibitory concentration (MIC) of compound was measured on Providencia rettgeri H1771 (gram negative organism),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123601,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,78008,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC,ug ml-1,UO_0000274,,0.025
12396,,,392163,[],CHEMBL762958,Minimum inhibitory concentration (MIC) of compound was measured on Pseudomonas aeruginosa UI-18(gram negative organism),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123601,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,78008,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
12397,,,392164,[],CHEMBL806751,Minimum inhibitory concentration (MIC) of compound was measured on Staphylococcus aureus H228 (gram positive organism),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123601,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,78008,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.8
12398,,,392165,[],CHEMBL806752,Minimum inhibitory concentration (MIC) of compound was measured on Staphylococcus aureus UC-76(gram positive organism),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123601,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,78008,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
12399,,,392166,[],CHEMBL812353,Minimum inhibitory concentration (MIC) of compound was measured on Streptococcus faecalis MGH-2(gram positive organism),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123601,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,78008,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.6
12400,,,392167,[],CHEMBL814191,Minimum inhibitory concentration (MIC) of compound was measured on Streptococcus pneumoniae SV-1(gram positive organism),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123601,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,78008,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.6
12401,,,392168,[],CHEMBL809200,Minimum inhibitory concentration (MIC) of compound was measured on Streptococcus pyogenes C203 (gram positive organism),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123601,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,78008,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.8
12402,,,392169,[],CHEMBL676285,Dose required to protect 50% of mice from lethal infection was measured on Escherichia coli vogel(peroral administration),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123601,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,78008,=,1,0,=,,PD50,mg kg-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,1.0
12403,,,392170,[],CHEMBL676286,Dose required to protect 50% of mice from lethal infection was measured on Escherichia coli vogel (subcutaneously),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123601,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,78008,=,1,0,=,,PD50,mg kg-1,,0.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,0.7
12404,,,392171,[],CHEMBL809397,Dose required to protect 50% of mice from lethal infection was measured on Streptococcus pyogenes C203 (p.o. administration),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123601,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,78008,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PD50,mg kg-1,UO_0000308,,100.0
12405,,,392172,[],CHEMBL809398,Dose required to protect 50% of mice from lethal infection was measured on Streptococcus pyogenes C203 (s.c.),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123601,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,78008,=,1,0,=,,PD50,mg kg-1,,45.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PD50,mg kg-1,UO_0000308,,45.0
12406,,,392173,[],CHEMBL812949,Dose required to protect 50% of mice from lethal infection was measured on Streptococcus pneumoniae SV-1(peroral administration),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123601,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,78008,=,1,0,=,,PD50,mg kg-1,,150.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,PD50,mg kg-1,UO_0000308,,150.0
12407,,,392174,[],CHEMBL812950,Dose required to protect 50% of mice from lethal infection was measured on Streptococcus pneumoniae SV-1 (subcutaneously),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123601,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,78008,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,PD50,mg kg-1,UO_0000308,,100.0
12408,,,392175,[],CHEMBL678372,Minimum concentration of compound needed to produce linear DNA at an intensity relative to oxolinic acid at 10 ug/mL was measured on Escherichia coli for gyrase-drug induced cleavage.,F,,,BAO_0002752,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123601,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,78008,=,1,0,=,,Concentration,ug ml-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Concentration,ug ml-1,UO_0000274,,1.0
12409,,,392176,[],CHEMBL674557,"Concentration of compound needed to produce linear DNA at an intensity relative to oxolinic acid at 10 ug/mL was measured on Escherichia coli for gyrase-drug induced cleavage,.",F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123601,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,78008,=,1,1,=,,IC50,ug.mL-1,,5.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IC50,ug ml-1,UO_0000274,,5.5
12410,,,417832,[],CHEMBL801729,Tested in vitro against Staphylococcus aureus FDA209P JC-1 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167701,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
12411,,,417833,[],CHEMBL805357,Tested in vitro against Staphylococcus epidermidis IAM12896 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167701,=,1,1,=,,MIC,ug.mL-1,,3.13,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,3.13
12412,,,417834,[],CHEMBL651227,Tested in vitro against Bacillus subtilis ATCC 6633 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167701,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.39
12413,,,417835,[],CHEMBL681533,Tested in vitro against Escherichia coli NIHJ JC-2 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167701,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.39
12414,,,417836,[],CHEMBL703026,Tested in vitro against Klebsiella pneumoniae PCI-602 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167701,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.1
12415,,,417837,[],CHEMBL767454,Tested in vitro against Proteus vulgaris OX-19 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167701,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.2
12416,,,417838,[],CHEMBL800637,Tested in vitro against Salmonella Typhimurium IID971 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167701,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.1
12417,,,417839,[],CHEMBL882145,Tested in vitro against Serratia marcescens IAM1184 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167701,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.78
12418,,,417840,[],CHEMBL753900,Tested in vitro against Pseudomonas aeruginosa IFO3445 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167701,=,1,1,=,,MIC,ug.mL-1,,3.13,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.13
12419,,,417841,[],CHEMBL801730,Tested in vitro against Staphylococcus aureus IID803 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167701,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.56
12420,,,417842,[],CHEMBL801728,Tested in vivo against Staphylococcus aureus IID803 in mice after peroral dose of drug with 0.5% sodium carboxy methyl cellulose,F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,167701,=,1,1,=,,ED50,mg.kg-1,,91.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,91.7
12421,,,417843,[],CHEMBL883414,Tested in vitro against Pseudomonas aeruginosa E-2 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,167701,=,1,1,=,,MIC,ug.mL-1,,3.13,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.13
12422,,,417844,[],CHEMBL753895,Tested in vivo against Pseudomonas aeruginosa E-2 in mice after peroral dose of drug with 0.5% sodium carboxy methyl cellulose,F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126799,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,167701,=,1,1,=,,ED50,mg.kg-1,,107.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,ED50,mg kg-1,UO_0000308,,107.0
12423,,,429055,[],CHEMBL647892,Minimum inhibitory concentration required for the antibacterial activity against Bacillus fragilis ES 25,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,16.0
12424,,,429056,[],CHEMBL649474,Minimum inhibitory concentration required for the antibacterial activity against Bacillus fragilis 06688,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,16.0
12425,,,429057,[],CHEMBL647891,Minimum inhibitory concentration required for the antibacterial activity against Bacillus fragilis DSM 2151,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,16.0
12426,,,429058,[],CHEMBL647896,Minimum inhibitory concentration required for the antibacterial activity against Bacillus fragilis L 1168 Italien,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,16.0
12427,,,429059,[],CHEMBL647894,Minimum inhibitory concentration required for the antibacterial activity against Bacillus fragilis Kr 1 TV,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,16.0
12428,,,429060,[],CHEMBL649475,Minimum inhibitory concentration required for the antibacterial activity against Bacillus fragilis 1560 I/82,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,16.0
12429,,,429061,[],CHEMBL649473,Minimum inhibitory concentration required for the antibacterial activity against Bacillus fragilis 010848,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,16.0
12430,,,429062,[],CHEMBL647895,Minimum inhibitory concentration required for the antibacterial activity against Bacillus fragilis Kr II,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,16.0
12431,,,429063,[],CHEMBL647893,Minimum inhibitory concentration required for the antibacterial activity against Bacillus fragilis GA I - 0558 Japan,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,16.0
12432,,,429064,[],CHEMBL649476,Minimum inhibitory concentration required for the antibacterial activity against Bacillus fragilis 2034/35 Kr 43,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,16.0
12433,,,429065,[],CHEMBL647890,Minimum inhibitory concentration required for the antibacterial activity against Bacillus fragilis 4891/91 Kr,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,16.0
12434,,,429066,[],CHEMBL649477,Minimum inhibitory concentration required for the antibacterial activity against Bacillus fragilis 4661 Kr,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,16.0
12435,,,429067,[],CHEMBL650447,Minimum inhibitory concentration required for the antibacterial activity against Bacillus thetaiotaomicron DSM 2079,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC,ug ml-1,UO_0000274,,16.0
12436,,,429068,[],CHEMBL650446,Minimum inhibitory concentration required for the antibacterial activity against Bacillus thetaiotaomicron 235 Munchen,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC,ug ml-1,UO_0000274,,16.0
12437,,,429069,[],CHEMBL649200,Minimum inhibitory concentration required for the antibacterial activity against Bacillus melaninogenicus Kr,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,,MIC,ug ml-1,UO_0000274,,16.0
12438,,,429070,[],CHEMBL649199,Minimum inhibitory concentration required for the antibacterial activity against Bacillus melaninogenicus Heidelberg,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,,MIC,ug ml-1,UO_0000274,,16.0
12439,,,429071,[],CHEMBL649201,Minimum inhibitory concentration required for the antibacterial activity against Bacillus ovatus Heidelberg,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,,MIC,ug ml-1,UO_0000274,,16.0
12440,,,429072,[],CHEMBL649467,Minimum inhibitory concentration required for the antibacterial activity against Bacillus distasonis Heidelberg,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,,MIC,ug ml-1,UO_0000274,,16.0
12441,,,429073,[],CHEMBL649468,Minimum inhibitory concentration required for the antibacterial activity against Bacillus distasonis Kr,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,,MIC,ug ml-1,UO_0000274,,16.0
12442,,,429074,[],CHEMBL650450,Minimum inhibitory concentration required for the antibacterial activity against Bacillus valgatus Kr III,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,MIC,ug ml-1,UO_0000274,,16.0
12443,,,429075,[],CHEMBL681400,Minimum inhibitory concentration required for the antibacterial activity against Fusobacterium nucleatum DSM 20482,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,,MIC,ug ml-1,UO_0000274,,16.0
12444,,,429076,[],CHEMBL805792,Minimum inhibitory concentration required for the antibacterial activity against Sphaerophorus necrophorus Kr,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614417,Fusobacterium necrophorum,Fusobacterium necrophorum,859.0,,,MIC,ug ml-1,UO_0000274,,2.0
12445,,,429077,[],CHEMBL659037,Minimum inhibitory concentration required for the antibacterial activity against Clostridium perfringens 1024027,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,2.0
12446,,,429078,[],CHEMBL659040,Minimum inhibitory concentration required for the antibacterial activity against Clostridium perfringens DSM 756,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,16.0
12447,,,429079,[],CHEMBL659038,Minimum inhibitory concentration required for the antibacterial activity against Clostridium perfringens 24071,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,4.0
12448,,,429080,[],CHEMBL659039,Minimum inhibitory concentration required for the antibacterial activity against Clostridium perfringens 24072,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,4.0
12449,,,429081,[],CHEMBL660464,Minimum inhibitory concentration required for the antibacterial activity against Clostridium ramosum DSM 1402,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614971,Thomasclavelia ramosa,Thomasclavelia ramosa,1547.0,,,MIC,ug ml-1,UO_0000274,,16.0
12450,,,429082,[],CHEMBL858494,Minimum inhibitory concentration required for the antibacterial activity against Clostridium septicum,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614968,Clostridium septicum,Clostridium septicum,1504.0,,,MIC,ug ml-1,UO_0000274,,16.0
12451,,,429083,[],CHEMBL660119,Minimum inhibitory concentration required for the antibacterial activity against Clostridium butyricum,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614964,Clostridium butyricum,Clostridium butyricum,1492.0,,,MIC,ug ml-1,UO_0000274,,16.0
12452,,,429084,[],CHEMBL660469,Minimum inhibitory concentration required for the antibacterial activity against Clostridium sporogenes,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614969,Clostridium sporogenes,Clostridium sporogenes,1509.0,,,MIC,ug ml-1,UO_0000274,,16.0
12453,,,429085,[],CHEMBL764403,Minimum inhibitory concentration required for the antibacterial activity against Peptostrept. anaer. DSM 20357,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,,MIC,ug ml-1,UO_0000274,,16.0
12454,,,429086,[],CHEMBL760153,Minimum inhibitory concentration required for the antibacterial activity against Peptostrept. anaer. Kr I,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,,MIC,ug ml-1,UO_0000274,,16.0
12455,,,429087,[],CHEMBL760154,Minimum inhibitory concentration required for the antibacterial activity against Peptostrept. anaer. Kr II,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,,MIC,ug ml-1,UO_0000274,,2.0
12456,,,429088,[],CHEMBL764402,Minimum inhibitory concentration required for the antibacterial activity against Peptostrept. anaer. 222 I/82,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,,MIC,ug ml-1,UO_0000274,,16.0
12457,,,429089,[],CHEMBL765441,Minimum inhibitory concentration required for the antibacterial activity against Peptococcus prevotii DSM 20548,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL612351,Anaerococcus prevotii,Anaerococcus prevotii,33034.0,,,MIC,ug ml-1,UO_0000274,,16.0
12458,,,429090,[],CHEMBL765271,Minimum inhibitory concentration required for the antibacterial activity against Peptococcus asacchar. DSM 20463,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1127134,Bioorg Med Chem Lett,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,125327,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,,MIC,ug ml-1,UO_0000274,,4.0
12459,,,556647,[],CHEMBL800036,Minimum inhibitory concentration tested against Staphylococcus aureus FDA207PJC-1,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124427,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,313167,=,1,1,=,,MIC,ug.mL-1,,190.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg ml-1,UO_0000274,,0.19
12460,,,556648,[],CHEMBL857911,Minimum inhibitory concentration tested against Bacillus subtilis ATCC 6633,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124427,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,313167,=,1,1,=,,MIC,ug.mL-1,,190.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,mg ml-1,UO_0000274,,0.19
12461,,,556649,[],CHEMBL674157,Minimum inhibitory concentration tested against Escherichia coli KC-14,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124427,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,313167,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg ml-1,UO_0000274,,0.1
12462,,,556650,[],CHEMBL705178,Minimum inhibitory concentration tested against Klebsiella pneumoniae PC1602,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124427,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,313167,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg ml-1,UO_0000274,,0.05
12463,,,556651,[],CHEMBL802510,Minimum inhibitory concentration tested against Serratia marcescens LAM 1184,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124427,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,313167,=,1,1,=,,MIC,ug.mL-1,,190.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,mg ml-1,UO_0000274,,0.19
12464,,,556652,[],CHEMBL753362,Minimum inhibitory concentration tested against Proteus vulgaris OX-19,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124427,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,313167,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,mg ml-1,UO_0000274,,0.05
12465,,,556653,[],CHEMBL754500,Minimum inhibitory concentration tested against Pseudomonas aeruginosa E-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124427,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,313167,=,1,1,=,,MIC,ug.mL-1,,390.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg ml-1,UO_0000274,,0.39
12466,,,556654,[],CHEMBL875982,Serum level of compound (50 mg/kg) after 0.25 hr of peroral administration in mice,A,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124427,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,313167,=,1,0,=,,Serum level,,,0.64,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum level,,,,0.64
12467,,,556655,[],CHEMBL630895,Serum level of compound (50 mg/kg) after 0.50 hr of peroral administration in mice,A,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124427,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,313167,=,1,0,=,,Serum level,,,1.48,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum level,,,,1.48
12468,,,556656,[],CHEMBL630896,Serum level of compound (50 mg/kg) after 1.0 hr of peroral administration in mice,A,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124427,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,313167,=,1,0,=,,Serum level,,,0.66,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum level,,,,0.66
12469,,,556657,[],CHEMBL630897,Serum level of compound (50 mg/kg) after 2.0 hr of peroral administration in mice,A,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124427,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,313167,=,1,0,=,,Serum level,,,0.26,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum level,,,,0.26
12470,,,556658,[],CHEMBL630898,Serum level of compound (50 mg/kg) after 3.0 hh of peroral administration in mice,A,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124427,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,313167,=,1,0,=,,Serum level,,,0.07,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum level,,,,0.07
12471,,,556659,[],CHEMBL630899,Serum level of compound (50 mg/kg) after 4.0h of peroral administration in mice,A,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124427,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,313167,=,1,0,=,,Serum level,,,0.21,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum level,,,,0.21
12472,,,556660,[],CHEMBL624135,Area under curve value of compound per hour after oral administration,A,,,BAO_0002120,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124427,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,313167,=,1,1,=,,AUC,ng.hr.mL-1,,1800.0,CHEMBL612558,,ADMET,,,,AUC,ug ml-1 hr-1,,,1.8
12473,,,556661,[],CHEMBL798725,Oral efficacy of compound after peroral administration on systemic infection by Staphylococcus aureus IID803,F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124427,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,313167,=,1,1,=,,ED50,mg.kg-1,,225.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,225.0
12474,,,556662,[],CHEMBL674154,Oral efficacy of compound after peroral administration on systemic infection by Escherichia coli KC-14,F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124427,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,313167,=,1,1,=,,ED50,mg.kg-1,,3.15,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,3.15
12475,,,556663,[],CHEMBL754499,Oral efficacy of compound after peroral administration on systemic infection by Pseudomonas aeruginosa E-2,F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124427,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,313167,=,1,1,=,,ED50,mg.kg-1,,77.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,ED50,mg kg-1,UO_0000308,,77.1
12476,,,556664,[],CHEMBL787488,Lethal dose of compound after peroral administration in rats,T,,,BAO_0002117,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124427,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,313167,>,1,1,>,,LD50,mg.kg-1,,4000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,LD50,mg kg-1,UO_0000308,,4000.0
12477,,,556665,[],CHEMBL674153,Effective dose of compound against Escherichia coli KC-14 in rats after oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124427,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,313167,=,1,1,=,,ED50,mg.kg-1,,3.13,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,3.13
12478,,,573339,[],CHEMBL755270,Minimum inhibitory concentration against Pseudomonas aeruginosa ATCC 15692 measured in Muller-Hinton (MH) solid media,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134513,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,119185,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
12479,,,573340,[],CHEMBL883400,Minimum inhibitory concentration against Pseudomonas aeruginosa ATCC 15692 measured in succinate (SC) solid media,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134513,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,119185,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.06
12480,,,573341,[],CHEMBL751850,"Minimum inhibitory concentration against Pseudomonas aeruginosa IAI, measured in Muller-Hinton (MH) solid media",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134513,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,119185,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
12481,,,573342,[],CHEMBL754502,Minimum inhibitory concentration against Pseudomonas aeruginosa IAI measured in succinate (SC) solid media,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134513,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,119185,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.03
12482,,,573343,[],CHEMBL857795,"Minimum inhibitory concentration against Pseudomonas aeruginosa K690, measured in Muller-Hinton (MH) solid media",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134513,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,119185,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
12483,,,573344,[],CHEMBL754838,"Minimum inhibitory concentration against Pseudomonas aeruginosa K690, measured in succinate (SC) solid media",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134513,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,119185,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
12484,,,573345,[],CHEMBL755864,Minimum inhibitory concentration against Pseudomonas aeruginosa ATCC 27853 measured in Muller-Hinton (MH) solid media,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134513,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,119185,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
12485,,,573346,[],CHEMBL755866,Minimum inhibitory concentration against Pseudomonas aeruginosa ATCC 27853 measured in succinate (SC) solid media,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134513,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,119185,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
12486,,,573347,[],CHEMBL686747,Minimum effective dose required for the inhibition of Escherichia coli gyrase,B,,,BAO_0000179,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134513,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,119185,=,1,0,=,,MED,mg kg-1,,1.0,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,MED,mg kg-1,UO_0000308,,1.0
12487,,,573348,[],CHEMBL755269,Minimum inhibitory concentration against Pseudomonas aeruginosa ATCC 15692 measured in Muller-Hinton (MH) liquid media,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134513,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,119185,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
12488,,,573349,[],CHEMBL755271,Minimum inhibitory concentration against Pseudomonas aeruginosa ATCC 15692 measured in succinate (SC) liquid media,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134513,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,119185,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
12489,,,573350,[],CHEMBL858167,"Minimum inhibitory concentration against Pseudomonas aeruginosa IAI, measured in Muller-Hinton (MH) liquid media",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134513,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,119185,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
12490,,,573351,[],CHEMBL754501,Minimum inhibitory concentration against Pseudomonas aeruginosa IAI measured in succinate (SC) liquid media,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134513,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,119185,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
12491,,,573352,[],CHEMBL755863,Minimum inhibitory concentration against Pseudomonas aeruginosa ATCC 27853 measured in Muller-Hinton (MH) liquid media,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134513,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,119185,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
12492,,,573353,[],CHEMBL755865,Minimum inhibitory concentration against Pseudomonas aeruginosa ATCC 27853 measured in succinate (SC) liquid media,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134513,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,119185,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
12493,,Not Active,591103,[],CHEMBL714242,Inhibitory activity against Lycopus europeus; no inhibitory activity,F,,,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146678,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,336909,,1,0,,,Inhibition,%,,,CHEMBL612533,Lycopus europaeus,Lycopus europaeus,260603.0,,,Inhibition,,UO_0000187,,
12494,,,591104,[],CHEMBL846966,Fold reduction in minimum inhibitory concentration of antibiotic in presence of Reserpine,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146678,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,336909,=,1,0,=,,Fold_reduction,,,4.0,CHEMBL612545,,Unchecked,,,,Fold_reduction,,,,4.0
12495,,,591105,[],CHEMBL846845,Fold reduction in minimum inhibitory concentration of antibiotic in presence of GG918,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146678,Bioorg Med Chem Lett,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,336909,=,1,0,=,,Fold_reduction,,,8.0,CHEMBL612545,,Unchecked,,,,Fold_reduction,,,,8.0
12496,,,596272,[],CHEMBL804633,Minimum inhibition concentration in vitro determined against Staphylococcus aureus ATCC 6538P,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1122831,J Med Chem,1985.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,63554,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
12497,,,596273,[],CHEMBL811169,Minimum inhibition concentration in vitro determined against Staphylococcus aureus CMX 686B,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1122831,J Med Chem,1985.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,63554,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
12498,,,596274,[],CHEMBL804396,Minimum inhibition concentration in vitro determined against Staphylococcus epidermidis 3519,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1122831,J Med Chem,1985.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,63554,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.56
12499,,,596275,[],CHEMBL811834,Minimum inhibition concentration in vitro determined against Streptococcus faecium ATCC 8043,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1122831,J Med Chem,1985.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,63554,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.78
12500,,,596276,[],CHEMBL811010,Minimum inhibition concentration in vitro determined against Streptococcus pyogenes 930,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1122831,J Med Chem,1985.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,63554,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,3.1
12501,,,596277,[],CHEMBL676922,Minimum inhibition concentration in vitro determined against Escherichia coli juhl ,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1122831,J Med Chem,1985.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,63554,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.1
12502,,,596278,[],CHEMBL679099,Minimum inhibition concentration in vitro determined against Enterobacteri aerogenes ATCC 13048,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1122831,J Med Chem,1985.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,63554,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.2
12503,,,596279,[],CHEMBL704188,Minimum inhibition concentration in vitro determined against Klebsiella pneumoniae 8045,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1122831,J Med Chem,1985.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,63554,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.1
12504,,,596280,[],CHEMBL763120,Minimum inhibition concentration in vitro determined against Pseudomona aeruginosa 5007,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1122831,J Med Chem,1985.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,63554,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.39
12505,,,596281,[],CHEMBL763121,Minimum inhibition concentration in vitro determined against Pseudomona aeruginosa K799/WT,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1122831,J Med Chem,1985.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,63554,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.39
12506,,,596282,[],CHEMBL857905,Minimum inhibition concentration in vitro determined against Acinetobacter sp CMX669,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1122831,J Med Chem,1985.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,63554,=,1,1,=,,MIC,ug.mL-1,,6.2,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,,MIC,ug ml-1,UO_0000274,,6.2
12507,,,596283,[],CHEMBL718586,In vivio inhibitory activity against Escherichia coli Juhl after subcutaneous administration in mice,F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1122831,J Med Chem,1985.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,63554,=,1,1,=,,ED50,mg.kg-1,,0.6,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,0.6
12508,,,596284,[],CHEMBL717104,In vivo inhibitory activity against Escherichia coli Juhl after peroral administration in mice,F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1122831,J Med Chem,1985.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,63554,=,1,1,=,,ED50,mg.kg-1,,15.1,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,15.1
12509,,,596285,[],CHEMBL676922,Minimum inhibition concentration in vitro determined against Escherichia coli juhl ,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1122831,J Med Chem,1985.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,63554,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.1
12510,,,601753,[],CHEMBL800037,Minimum inhibition concentration against Staphylococcus aureus FDA209P strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41457,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
12511,,,601754,[],CHEMBL807554,Minimum inhibition concentration against Staphylococcus aureus MRSA strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41457,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,12.5
12512,,,601755,[],CHEMBL804725,Minimum inhibition concentration against Streptococcus pneumoniae Type I strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41457,=,1,1,=,,MIC,ug.mL-1,,3.13,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,3.13
12513,,,601756,[],CHEMBL675160,Minimum inhibition concentration against Enterococcus faecalis LS-101 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41457,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.78
12514,,,601757,[],CHEMBL672322,Minimum inhibition concentration against Escherichia coli NIHJ JC-2 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41457,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.1
12515,,,601758,[],CHEMBL756153,Minimum inhibition concentration against Pseudomonas aeruginosa U-31 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41457,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.39
12516,,,601759,[],CHEMBL682993,Percentage of GABA-induced chloride currents with compound alone at 10 e-4 M,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,41457,=,1,0,=,,Currents,%,,38.0,CHEMBL2093872,Homo sapiens,GABA-A receptor; anion channel,9606.0,,,Currents,%,UO_0000187,,38.0
12517,,,601760,[],CHEMBL682991,Percentage of GABA-induced chloride currents with 10 e-5 M 4-biphenylacetic acid,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,41457,=,1,0,=,,Currents,%,,0.0,CHEMBL2093872,Homo sapiens,GABA-A receptor; anion channel,9606.0,,,Currents,%,UO_0000187,,0.0
12518,,,601761,[],CHEMBL856170,Inhibition of [3H]muscimol binding to GABA A receptor with compound alone at 10 e-4 M,B,,,BAO_0000190,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126682,J Med Chem,1993.0,"{'bei': '15.30', 'le': '0.29', 'lle': '3.62', 'sei': '6.55'}",CHEMBL9,NORFLOXACIN,CHEMBL9,4.89,0,http://www.openphacts.org/units/Nanomolar,41457,=,1,1,=,,IC50,nM,,13000.0,CHEMBL1907607,Rattus norvegicus,GABA-A receptor; anion channel,10116.0,,,IC50,M,UO_0000065,,1.3e-05
12519,,,601762,[],CHEMBL681272,Inhibition of [3H]muscimol binding to GABA A receptor 4-biphenylacetic acid at 10 e-4 M,B,,,BAO_0000190,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126682,J Med Chem,1993.0,"{'bei': '24.11', 'le': '0.46', 'lle': '6.43', 'sei': '10.32'}",CHEMBL9,NORFLOXACIN,CHEMBL9,7.7,0,http://www.openphacts.org/units/Nanomolar,41457,=,1,1,=,,IC50,nM,,20.0,CHEMBL1907607,Rattus norvegicus,GABA-A receptor; anion channel,10116.0,,,IC50,M,UO_0000065,,2e-08
12520,,,601763,[],CHEMBL716311,Percentage of mice with convulsion with compound alone at 400 mg/kg,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,41457,=,1,0,=,,Convulsion,%,,0.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Convulsion,%,UO_0000187,,0.0
12521,,,601764,[],CHEMBL716310,Percentage of mice with convulsion (400 mg/kg fenbufen),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,41457,=,1,0,=,,Convulsion,%,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Convulsion,%,UO_0000187,,100.0
12522,,,601765,[],CHEMBL804053,Minimum inhibitory concentration against Staphylococcus aureus Smith,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41457,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
12523,,,601766,[],CHEMBL735951,Effective dose against Staphylococcus aureus smith strain in mouse,F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,41457,=,1,0,=,,ED50,mg mouse-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg mouse-1,,,1.0
12524,,,601767,[],CHEMBL674442,Minimum inhibitory concentration against Escherichia coli KC14 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41457,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
12525,,,601768,[],CHEMBL735950,Effective dose against Escherichia coli KC14 strain in mouse,F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,41457,=,1,0,=,,ED50,mg mouse-1,,0.054,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg mouse-1,,,0.054
12526,,,601769,[],CHEMBL636866,Calculated partition coefficient (clogP),P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,41457,=,1,1,=,,CLogP,,,0.32,CHEMBL2362975,,No relevant target,,,,clogP,,,,0.32
12527,,,601770,[],CHEMBL636984,The compound was evaluated for the solubility in water at 25 degrees Centigrade,A,,,BAO_0002135,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126682,J Med Chem,1993.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41457,=,1,1,=,,Solubility,ug.mL-1,,290.0,CHEMBL612558,,ADMET,,,,Solubility,ug ml-1,UO_0000274,,290.0
12528,,,602521,[],CHEMBL808028,In vitro antibacterial activity against clinical isolates of Staphylococcus aureus 18773 (gram-positive) by agar dilution assay.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123921,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,277585,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.19
12529,,,602522,[],CHEMBL679873,In vitro antibacterial activity against clinical isolates of Escherichia coli 15 (gram negative) by agar dilution assay.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123921,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,277585,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.19
12530,,,602523,[],CHEMBL766577,In vitro antibacterial activity against clinical isolates of Pseudomonas aeruginosa 2437 (gram negative) by agar dilution assay.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123921,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,277585,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.56
12531,,,602524,[],CHEMBL764057,In vitro antibacterial activity against clinical isolates of Proteus morganii 27 (gram negative) by agar dilution assay.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123921,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,277585,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.78
12532,,,602525,[],CHEMBL700062,In vitro antibacterial activity against clinical isolates of Klebsiella pneumoniae-4 (gram negative) by agar dilution assay.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123921,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,277585,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.19
12533,,,602526,[],CHEMBL678580,In vitro antibacterial activity against clinical isolates of Enterobacter cloacae 041 (gram negative) by agar dilution assay.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123921,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,277585,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.39
12534,,,605191,[],CHEMBL858623,The compound was tested for its antimicrobial activity against Staphylococcus aureus ATCC 6538P (Sa(A)) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109441,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
12535,,,605192,[],CHEMBL810469,The compound was tested for its antimicrobial activity against Staphylococcus aureus CMX 68613 (Sa) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109441,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
12536,,,605193,[],CHEMBL813753,The compound was tested for its antimicrobial activity against Staphylococcus epidermidis 3519 (Se) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109441,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.56
12537,,,605194,[],CHEMBL811315,The compound was tested for its antimicrobial activity against Streptococcus faecium ATCC 8043 (Sf) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109441,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.78
12538,,,605195,[],CHEMBL809709,The compound was tested for its antimicrobial activity against Streptococcus pyogenes 930 (Sp) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109441,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,3.1
12539,,,605196,[],CHEMBL676923,The compound was tested for its antimicrobial activity against Escherichia coli juhl (Ec) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109441,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.1
12540,,,605197,[],CHEMBL677681,The compound was tested for its antimicrobial activity against Enterobacter aerogenes ATCC 13048 (Ea) strain.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109441,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.2
12541,,,605198,[],CHEMBL701262,The compound was tested for its antimicrobial activity against Klebsiella pneumoniae 8045 (Kp) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109441,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.1
12542,,,605199,[],CHEMBL771543,The compound was tested evaluated for its antimicrobial activity against Pseudomonas aeruginosa A5007 (Pa(5)) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109441,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.39
12543,,,605200,[],CHEMBL770338,The compound was tested evaluated for its antimicrobial activity against Pseudomonas aeruginosa ( Pa(K)) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109441,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.39
12544,,,605201,[],CHEMBL877636,The compound was tested for its antimicrobial activity against Acinetobacter sp. CMX 669 (A) strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109441,=,1,1,=,,MIC,ug.mL-1,,6.2,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,,MIC,ug ml-1,UO_0000274,,6.2
12545,,,605202,[],CHEMBL727007,The compound was tested for inhibition constant against DNA gyrase isolated from micrococcus luteus,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109441,=,1,1,=,,MIC,ug.mL-1,,72.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,72.0
12546,,,605203,[],CHEMBL681148,The compound was tested for inhibition constant against DNA gyrase isolated from Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123248,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,109441,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
12547,,,617239,[],CHEMBL676652,Evaluated for minimum inhibitory concentration against gram-negative bacteria Enterobacter cloacae HA 2646,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130655,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.1
12548,,,617240,[],CHEMBL682391,Evaluated for minimum inhibitory concentration against gram-negative bacteria Escherichia coli Vogel,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130655,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.1
12549,,,617241,[],CHEMBL701615,Evaluated for minimum inhibitory concentration against gram-negative bacteria Klebsiella pneumoniae MGH-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130655,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.2
12550,,,617242,[],CHEMBL768023,Evaluated for minimum inhibitory concentration against gram-negative bacteria Pseudomonas rettgeri H1771,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130655,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL612498,Pseudomonas,Pseudomonas,286.0,,,MIC,ug ml-1,UO_0000274,,0.2
12551,,,617243,[],CHEMBL766010,Evaluated for minimum inhibitory concentration against gram-negative bacteria Pseudomonas aeruginosa UI-18,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130655,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.8
12552,,,617244,[],CHEMBL809030,Evaluated for minimum inhibitory concentration against gram-negative bacteria Staphylococcus aureus H228,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130655,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,3.1
12553,,,617245,[],CHEMBL809031,Evaluated for minimum inhibitory concentration against gram-negative bacteria Staphylococcus aureus UC-76,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130655,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.4
12554,,,617246,[],CHEMBL811546,Evaluated for minimum inhibitory concentration against gram-negative bacteria Staphylococcus faecalis MGH-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130655,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,3.1
12555,,,617247,[],CHEMBL807300,Evaluated for minimum inhibitory concentration against gram-negative bacteria Staphylococcus pneumoniae SV-1,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130655,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,3.1
12556,,,617248,[],CHEMBL806108,Evaluated for minimum inhibitory concentration against gram-negative bacteria Staphylococcus pyogenes C203,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130655,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,3.1
12557,,,617249,[],CHEMBL682218,Evaluated for minimum concentration needed to produce linear DNA at an intensity relative to oxolinic acid at 10 mg/mL. by gyrase mediated cleavage of DNA in Escherichia coli 560.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125136,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,130655,=,1,1,=,,MIC,ug.mL-1,,5.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,5.2
12558,,,618638,[],CHEMBL809464,Antibacterial activity against Staphylococcus aureus GmR Meth (4310),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
12559,,,618639,[],CHEMBL809456,Antibacterial activity against Staphylococcus aureus (2868),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
12560,,,618640,[],CHEMBL809455,Antibacterial activity against Staphylococcus aureus (2865),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
12561,,,618641,[],CHEMBL813260,Antibacterial activity against Strep. faecalis (2864),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,8.0
12562,,,618642,[],CHEMBL677156,Antibacterial activity against Escherichia coli TEM 2+ (4351),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
12563,,,618643,[],CHEMBL677156,Antibacterial activity against Escherichia coli TEM 2+ (4351),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
12564,,,618644,[],CHEMBL682213,Antibacterial activity against Escherichia coli TEM 2+ DC2 (4352),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
12565,,,618645,[],CHEMBL677155,Antibacterial activity against Escherichia coli DC2 (4353),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
12566,,,618646,[],CHEMBL677154,Antibacterial activity against Escherichia coli (2891),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
12567,,,618647,[],CHEMBL803302,Antibacterial activity against Sal. Typhimurium (3860),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.5
12568,,,618648,[],CHEMBL676391,Antibacterial activity against Ent. cloacae 99+ (2646),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,1.0
12569,,,618649,[],CHEMBL676393,Antibacterial activity against Ent. cloacae P99- (2647),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.25
12570,,,618650,[],CHEMBL676387,Antibacterial activity against Ent. aerogenes (2828),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.5
12571,,,618651,[],CHEMBL700132,Antibacterial activity against Klebsiella pneumoniae K1+ (4354),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
12572,,,618652,[],CHEMBL700129,Antibacterial activity against Klebsiella pneumoniae (4005),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.06
12573,,,618653,[],CHEMBL762408,Antibacterial activity against Prot. vulgaris (2829),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.06
12574,,,618654,[],CHEMBL764055,Antibacterial activity against Prot. morganii SmR (2833),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.06
12575,,,618655,[],CHEMBL765012,Antibacterial activity against Prot. mirabilis GmR (2830),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.06
12576,,,618656,[],CHEMBL770154,Antibacterial activity against Ps. aeruginosa RPL11+ (3350),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
12577,,,618657,[],CHEMBL770152,Antibacterial activity against Ps. aeruginosa (2835),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
12578,,,618658,[],CHEMBL770153,Antibacterial activity against Ps. aeruginosa (4279),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
12579,,,618659,[],CHEMBL858044,Antibacterial activity against Ser. marcescens (2840),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,4.0
12580,,,618660,[],CHEMBL622868,Serum conc at 3 hours following 25 mg/kg dose,A,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,0,=,,Concentration_plasma,ug ml-1,,0.76,CHEMBL612558,,ADMET,,,,Concentration_plasma,ug ml-1,UO_0000274,,0.76
12581,,,618661,[],CHEMBL622869,Urine conc 0-5 hours following 25 mg/kg dose,A,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,0,=,,Concentration_urine,ug ml-1,,175.86,CHEMBL612558,,ADMET,,,,Concentration_urine,ug ml-1,UO_0000274,,175.86
12582,,,618662,[],CHEMBL622870,Urine conc 0-24 hours following 25 mg/kg dose,A,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,0,=,,Concentration_urine,ug ml-1,,33.78,CHEMBL612558,,ADMET,,,,Concentration_urine,ug ml-1,UO_0000274,,33.78
12583,,,618663,[],CHEMBL730158,% dose recovered in urine,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,328847,=,1,0,=,,Dose,%,,16.3,CHEMBL614874,Cercopithecidae,Monkey,9527.0,,,Dose,%,UO_0000187,,16.3
12584,,,618664,[],CHEMBL635784,Solubility in water at 25 degree Centigrade,P,,,BAO_0002135,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,Solubility,ug.mL-1,,190.0,CHEMBL2362975,,No relevant target,,,,S,mg ml-1,UO_0000274,,0.19
12585,,,618665,[],CHEMBL633628,Solubility in citrate buffer (0.1 M) at 25 degree centigrade(pH 5),P,,,BAO_0002135,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,Solubility,ug.mL-1,,8000.0,CHEMBL2362975,,No relevant target,,,,S,mg ml-1,UO_0000274,,8.0
12586,,,618666,[],CHEMBL633637,Solubility in phosphate buffer (0.1 M) at 25 degree centigrade(pH 7.4),P,,,BAO_0002135,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,Solubility,ug.mL-1,,200.0,CHEMBL2362975,,No relevant target,,,,Solubility,mg ml-1,UO_0000274,,0.2
12587,,,618667,[],CHEMBL876222,Solubility in bicarbonate buffer (0.05 M) at 25 degree centigrade(pH 8.5),P,,,BAO_0002135,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125758,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,328847,=,1,1,=,,Solubility,ug.mL-1,,210.0,CHEMBL2362975,,No relevant target,,,,S,mg ml-1,UO_0000274,,0.21
12588,,,618712,[],CHEMBL672106,"Antibacterial activity was determined against gram negative organism, Enterobacter cloacae MA2646",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16841,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.1
12589,,,618713,[],CHEMBL674330,"Antibacterial activity was determined against gram negative organism, Escherichia coli vogel",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16841,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
12590,,,618714,[],CHEMBL702642,"Antibacterial activity was determined against gram negative organism, Klebsiella pneumoniae MGH-2",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16841,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
12591,,,618715,[],CHEMBL755847,"Antibacterial activity was determined against gram negative organism, Providencia rettgeri. M1771",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16841,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL612490,Bacteria,Bacteria,2.0,,,MIC,ug ml-1,UO_0000274,,0.025
12592,,,618716,[],CHEMBL754839,"Antibacterial activity was determined against gram negative organism, Pseudomonas aeruginosa UI-18",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16841,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
12593,,,618717,[],CHEMBL805138,"Antibacterial activity was determined against gram positive organism, Staphylococcus aureus H228",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16841,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.8
12594,,,618718,[],CHEMBL805139,"Antibacterial activity was determined against gram positive organism, Staphylococcus aureus UC76",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16841,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
12595,,,618719,[],CHEMBL799853,"Antibacterial activity was determined against gram positive organism, Streptococcus faecalis MGH-2",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16841,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.6
12596,,,618720,[],CHEMBL799745,"Antibacterial activity was determined against gram positive organism, Streptococcus pneumoniae SV-1",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16841,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.6
12597,,,618721,[],CHEMBL801925,"Antibacterial activity was determined against gram positive organism, Streptococcus pyogenes C203",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16841,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.8
12598,,,618722,[],CHEMBL664853,Minimum inhibitory concentration against Escherichia coli DNA-gyrase supercoiling assay,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,1,http://www.openphacts.org/units/MicrogramPerMilliliter,16841,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
12599,,,618723,[],CHEMBL847743,MIC ratio measured as the mean MICs of gram-negative bacteria,F,,,BAO_0000193,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,16841,=,1,0,=,,Ratio,,,0.057,CHEMBL612545,,Unchecked,,,,Ratio,,,,0.057
12600,,,618724,[],CHEMBL847745,MIC ratio measured as the mean MICs of gram-positive bacteria,F,,,BAO_0000193,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125826,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,16841,=,1,0,=,,Ratio,,,0.61,CHEMBL612545,,Unchecked,,,,Ratio,,,,0.61
12601,,Impermeable,654902,[],CHEMBL741257,BBB penetration classification,A,,,BAO_0002808,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1133022,J Med Chem,2000.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,124815,,1,0,,,Permeability,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Permeability,,,,
12602,,,681889,[],CHEMBL673972,Biological activity against Escherichia coli N1HJ JC-2 relative to Norfloxacin.,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125906,J Med Chem,1991.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,44191,=,1,0,=,,pMIC,M l-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,pMIC,M l-1,,,4.0
12603,,,685861,[],CHEMBL682196,In vitro antimicrobial activity against Escherichia coli was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1133085,J Med Chem,2000.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,238520,=,1,1,=,,MIC,nM,,630.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,0.63
12604,,,685862,[],CHEMBL751647,In vitro antimicrobial activity against Mycobacterium ranae was determined,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1133085,J Med Chem,2000.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,238520,=,1,1,=,,MIC,nM,,9800.0,CHEMBL612545,,Unchecked,,,,MIC,uM,UO_0000065,,9.8
12605,,,685863,[],CHEMBL767121,In vitro antimicrobial activity against Pseudomonas aeruginosa was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1133085,J Med Chem,2000.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,238520,=,1,1,=,,MIC,nM,,1220.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,1.22
12606,,,685864,[],CHEMBL703010,In vitro antimicrobial activity against Klebsiella pneumoniae was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1133085,J Med Chem,2000.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,238520,=,1,1,=,,MIC,nM,,41.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,uM,UO_0000065,,0.041
12607,,,685865,[],CHEMBL769334,In vitro antimicrobial activity against Proteus vulgaris was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1133085,J Med Chem,2000.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,238520,=,1,1,=,,MIC,nM,,160.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,uM,UO_0000065,,0.16
12608,,,685866,[],CHEMBL807219,In vitro antimicrobial activity against Staphylococcus aureus (methicillin-resistant) was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1133085,J Med Chem,2000.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,238520,=,1,1,=,,MIC,nM,,4890.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,4.89
12609,,,685867,[],CHEMBL807301,In vitro antimicrobial activity against Staphylococcus pneumoniae (erythromycin and ampicillin-resistant) was determined,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1133085,J Med Chem,2000.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,238520,=,1,1,=,,MIC,nM,,19600.0,CHEMBL612545,,Unchecked,,,,MIC,uM,UO_0000065,,19.6
12610,,,685868,[],CHEMBL673603,In vitro antimicrobial activity against Enterococcus faecalis (vancomycin-resistant) was determined,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1133085,J Med Chem,2000.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,238520,=,1,1,=,,MIC,nM,,9800.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,uM,UO_0000065,,9.8
12611,,,728671,[],CHEMBL808758,Minimum inhibitory concentration tested against Staphylococcus aureus 1199 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1136390,Bioorg Med Chem Lett,2003.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,81511,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
12612,,,728672,[],CHEMBL808759,Minimum inhibitory concentration tested against Staphylococcus aureus 1199-3 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1136390,Bioorg Med Chem Lett,2003.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,81511,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
12613,,,728673,[],CHEMBL808760,Minimum inhibitory concentration tested against Staphylococcus aureus 1199B strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1136390,Bioorg Med Chem Lett,2003.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,81511,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
12614,,,728674,[],CHEMBL808761,Minimum inhibitory concentration tested against methicillin resistant Staphylococcus aureus 494 strain (MRSA 494),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1136390,Bioorg Med Chem Lett,2003.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,81511,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
12615,,,728675,[],CHEMBL808830,Minimum inhibitory concentration tested against vancomycin-insensitive SA (GISA 992 strain),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1136390,Bioorg Med Chem Lett,2003.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,81511,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
12616,,,782165,[],CHEMBL674481,In vitro minimum inhibitory concentration against growth of Escherichia coli Vogel,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1122812,J Med Chem,1984.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,11984,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
12617,,,782166,[],CHEMBL704685,In vitro minimum inhibitory concentration against growth of Klebsiella pneumoniae strain 39645,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1122812,J Med Chem,1984.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,11984,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
12618,,,782167,[],CHEMBL769407,In vitro minimum inhibitory concentration against growth of Pseudomonas aeruginosa MGH-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1122812,J Med Chem,1984.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,11984,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
12619,,,782168,[],CHEMBL810480,In vitro minimum inhibitory concentration against growth of Staphylococcus aureus Smith,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1122812,J Med Chem,1984.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,11984,=,1,1,=,,MIC,ug.mL-1,,1.95,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.95
12620,,,782169,[],CHEMBL743062,Antibacterial activity in mice after intraperitoneal administration with 0.5 mL of Escherichia coli Vogel inoculum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1122812,J Med Chem,1984.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,11984,=,1,0,=,,PD50,mg kg-1,,0.3,CHEMBL3879801,,NON-PROTEIN TARGET,,,,PD50,mg kg-1,UO_0000308,,0.3
12621,,,782170,[],CHEMBL743063,Compound was evaluated for antibacterial activity in mice after peroral administration with 0.5 mL of Escherichia coli Vogel inoculum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1122812,J Med Chem,1984.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,11984,=,1,0,=,,PD50,mg kg-1,,5.9,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,5.9
12622,,,866426,[],CHEMBL814303,"In vitro antibacterial activity against Gram-positive, Staphylococcus aureus 209 P",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1121603,J Med Chem,1980.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41543,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
12623,,,866427,[],CHEMBL675523,In vitro for antibacterial activity against Gram-negative Escherichia coli NIJH JC-2.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1121603,J Med Chem,1980.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41543,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
12624,,,866428,[],CHEMBL768331,In vitro antibacterial activity against Gram-negative Pseudomonas aeruginosa V-1.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1121603,J Med Chem,1980.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,41543,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.39
12625,,,896760,[],CHEMBL724257,Serum concentration of the liberated Norfloxacin after oral administration (100 mg/kg) in mice after 0.5 hr,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124684,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Hour,314034,=,1,0,=,,Serum concentration,hr,,3.47,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,hr,UO_0000032,,3.47
12626,,,896761,[],CHEMBL724259,Serum concentration of the liberated Norfloxacin after oral administration (100 mg/kg) in mice after 1.0 hr,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124684,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Hour,314034,=,1,0,=,,Serum concentration,hr,,2.02,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,hr,UO_0000032,,2.02
12627,,,896762,[],CHEMBL724822,Serum concentration of the liberated Norfloxacin after oral administration (100 mg/kg) in mice after 2.0 hr,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124684,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Hour,314034,=,1,0,=,,Serum concentration,hr,,1.12,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,hr,UO_0000032,,1.12
12628,,,896763,[],CHEMBL724824,Serum concentration of the liberated Norfloxacin after oral administration (100 mg/kg) in mice after 4.0h,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124684,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Hour,314034,=,1,0,=,,Serum concentration,hr,,0.56,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,hr,UO_0000032,,0.56
12629,,,896764,[],CHEMBL619439,Compound was evaluated for Area under curve in mice,A,,,BAO_0002120,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124684,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,314034,=,1,1,=,,AUC,ng.hr.mL-1,,6490.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,ug hr ml-1,,,6.49
12630,,,902939,[],CHEMBL727938,Serum concentration of the liberated Norfloxacin after oral administration 100 mg/kg in mice after the 0.5 h,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124684,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,314037,=,1,0,=,,Serum concentration,,,3.47,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,3.47
12631,,,902940,[],CHEMBL724254,Serum concentration of the liberated Norfloxacin after oral administration 100 mg/kg in mice after the 1.0 h,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124684,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,314037,=,1,0,=,,Serum concentration,,,2.02,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,2.02
12632,,,902941,[],CHEMBL724255,Serum concentration of the liberated Norfloxacin after oral administration 100 mg/kg in mice after the 2.0 h,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124684,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,314037,=,1,0,=,,Serum concentration,,,1.12,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,1.12
12633,,,902942,[],CHEMBL724256,Serum concentration of the liberated Norfloxacin after oral administration 100 mg/kg in mice after the 4.0 h,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124684,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,314037,=,1,0,=,,Serum concentration,,,0.56,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Serum concentration,,,,0.56
12634,,,902943,[],CHEMBL619439,Compound was evaluated for Area under curve in mice,A,,,BAO_0002120,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124684,J Med Chem,1989.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,314037,=,1,1,=,,AUC,ng.hr.mL-1,,6490.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,ug hr ml-1,,,6.49
12635,,,1026831,[],CHEMBL652099,In vitro antibacterial activity against aerobically grown Bordetella bronchiseptica (73A009),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126160,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,307216,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL612286,Bordetella bronchiseptica,Bordetella bronchiseptica,518.0,,,MIC,ug ml-1,UO_0000274,,6.25
12636,,,1026832,[],CHEMBL675591,In vitro antibacterial activity against aerobically grown Escherichia coli (51A538),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126160,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,307216,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.1
12637,,,1026833,[],CHEMBL759640,In vitro antibacterial activity against Aerobically grown Pasteurella haemolytica (59B018),F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126160,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,307216,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,0.05
12638,,,1026834,[],CHEMBL763918,In vitro antibacterial activity against aerobically grown Pasteurella multocida (59A006),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126160,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,307216,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,MIC,ug ml-1,UO_0000274,,0.05
12639,,,1026835,[],CHEMBL803215,In vitro antibacterial activity against aerobically grown Salmonella choleraesuis (58B015),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126160,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,307216,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,,MIC,ug ml-1,UO_0000274,,0.1
12640,,,1026836,[],CHEMBL808893,In vitro antibacterial activity against aerobically grown Staphylococcus aureus (54B004),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126160,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,307216,=,1,1,=,,MIC,ug.mL-1,,3.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,3.13
12641,,,1026837,[],CHEMBL636954,In vitro antibacterial activity against anaerobically grown Actinobacillus pleuropneumoniae (54B004),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126160,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,307216,<,1,1,<,,MIC,ug.mL-1,,0.05,CHEMBL614603,Actinobacillus pleuropneumoniae,Actinobacillus pleuropneumoniae,715.0,,,MIC,ug ml-1,UO_0000274,,0.05
12642,,,1026838,[],CHEMBL636964,In vitro antibacterial activity against anaerobically grown Actinomyces pyogenes (14D002),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126160,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,307216,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL612637,Trueperella pyogenes,Trueperella pyogenes,1661.0,,,MIC,ug ml-1,UO_0000274,,12.5
12643,,,1026839,[],CHEMBL651592,In vitro antibacterial activity against anaerobically grown Bacteroides vulgatus (78D029),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126160,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,307216,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,MIC,ug ml-1,UO_0000274,,25.0
12644,,,1026840,[],CHEMBL874857,In vitro antibacterial activity against anaerobically grown Clostridium perfringens (10A009),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126160,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,307216,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,0.39
12645,,,1026841,[],CHEMBL813583,In vitro evaluation for antibacterial activity against anaerobically grown Treponema hyodysenteriae (94A007),F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126160,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,307216,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,6.25
12646,,,1026842,[],CHEMBL677043,Escherichia coli DNA cleavage endpoint value which is the minimum amount required (in micro g/mL) to induce detectable cleavage of supercoiled pBR322 substrate to linear form (gyrase),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126160,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,307216,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.78
12647,,,1026843,[],CHEMBL764526,In vivo protective dose was evaluated against Pasteurella multocida (59A006) in mouse(po),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126160,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,307216,=,1,0,=,,PD50,mg kg-1,,0.63,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,PD50,mg kg-1,UO_0000308,,0.63
12648,,,1026844,[],CHEMBL764527,In vivo protective dose was evaluated against Pasteurella multocida (59A006) in mouse(sc),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126160,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,307216,=,1,0,=,,PD50,mg kg-1,,5.54,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,PD50,mg kg-1,UO_0000308,,5.54
12649,,,1026845,[],CHEMBL675587,In vivo protective dose was evaluated against Escherichia coli (51A266) in mouse(po),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126160,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,307216,=,1,0,=,,PD50,mg kg-1,,8.84,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,8.84
12650,,,1026846,[],CHEMBL675588,In vivo protective dose was evaluated against Escherichia coli (51A266) in mouse(sc),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126160,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,307216,=,1,0,=,,PD50,mg kg-1,,0.46,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,0.46
12651,,,1026847,[],CHEMBL634764,Compound was evaluated for aqueous solubility at pH 7.2,P,,,BAO_0002135,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126160,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,307216,=,1,1,=,,Solubility,ug.mL-1,,350.0,CHEMBL2362975,,No relevant target,,,,Solubility,mg ml-1,UO_0000274,,0.35
12652,,,1037124,[],CHEMBL858478,In vitro antibacterial activity against Staphylococcus aureus FDA 209P JC-1,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123556,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120622,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
12653,,,1037125,[],CHEMBL808918,In vitro antibacterial activity against Staphylococcus epidermidis IAM 1576,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123556,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120622,=,1,1,=,,MIC,ug.mL-1,,3.13,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,3.13
12654,,,1037126,[],CHEMBL651198,In vitro antibacterial activity against Bacillus subtilis ATCC 6633,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123556,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120622,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.39
12655,,,1037127,[],CHEMBL857833,In vitro antibacterial activity against Escherichia coli NIHJ JC-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123556,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120622,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.39
12656,,,1037128,[],CHEMBL700061,In vitro antibacterial activity against Klebsiella pneumoniae PCI-602,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123556,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120622,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.1
12657,,,1037129,[],CHEMBL767770,In vitro antibacterial activity against Proteus vulgaris HX-19,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123556,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120622,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.1
12658,,,1037130,[],CHEMBL801479,In vitro antibacterial activity against Salmonella paratyphi 1015,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123556,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120622,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL612293,Salmonella enterica subsp. enterica serovar Paratyphi A,Salmonella paratyphi,54388.0,,,MIC,ug ml-1,UO_0000274,,0.1
12659,,,1037131,[],CHEMBL770215,In vitro antibacterial activity against Pseudomonas aeruginosa IFO 3445,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123556,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120622,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.56
12660,,,1037132,[],CHEMBL717869,In vivo antibacterial activity against Escherichia coli (KC-14) was determined for the compound administered perorally; Value ranges from 4.8-9.4,F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123556,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,120622,=,1,1,=,,ED50,mg.kg-1,,6.7,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,6.7
12661,,,1037133,[],CHEMBL728022,In vivo acute toxicity against Escherichia coli (KC-14) was determined for the compound administered orally,A,,,BAO_0002117,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123556,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,120622,=,1,1,=,,LD50,mg.kg-1,,4000.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,LD50,mg kg-1,UO_0000308,,4000.0
12662,,,1037134,[],CHEMBL725789,In vivo acute toxicity against Escherichia coli (KC-14) was determined for the compound administered intravenously,A,,,BAO_0002117,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123556,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,120622,=,1,1,=,,LD50,mg.kg-1,,327.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,LD50,mg kg-1,UO_0000308,,327.0
12663,,,1037135,[],CHEMBL634692,Concentrations in serum after 30 minutes at 50 mg / kg oral administration,A,,,BAO_0000179,BAO_0000366,cell-free format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123556,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120622,=,1,0,=,,Concentration in serum,ug ml-1,,1.05,CHEMBL612558,,ADMET,,,,Concentration in serum,ug ml-1,UO_0000274,,1.05
12664,,,1037136,[],CHEMBL634693,Concentrations in serum after 60 minutes at 50 mg / kg oral administration,A,,,BAO_0000179,BAO_0000366,cell-free format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123556,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120622,=,1,0,=,,Concentration in serum,ug ml-1,,0.69,CHEMBL612558,,ADMET,,,,Concentration in serum,ug ml-1,UO_0000274,,0.69
12665,,,1037137,[],CHEMBL634690,Concentrations in serum after 120 minutes at 50 mg / kg oral administration,A,,,BAO_0000179,BAO_0000366,cell-free format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123556,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120622,=,1,0,=,,Concentration in serum,ug ml-1,,0.4,CHEMBL612558,,ADMET,,,,Concentration in serum,ug ml-1,UO_0000274,,0.4
12666,,,1037138,[],CHEMBL634691,Concentrations in serum after 240 minutes at 50 mg / kg oral administration,A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123556,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120622,=,1,0,=,,Concentration in serum,ug ml-1,,0.36,CHEMBL612558,,ADMET,,,,Concentration in serum,ug ml-1,UO_0000274,,0.36
12667,,,1037139,[],CHEMBL634694,Total serum concentrations at 0 to 4 hours interval was determined by 50 mg / kg oral administration,A,,,BAO_0000179,BAO_0000366,cell-free format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123556,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,120622,=,1,0,=,,Concentration in serum,ug ml-1,,2.0,CHEMBL612558,,ADMET,,,,Concentration in serum,ug ml-1,UO_0000274,,2.0
12668,,,1080788,[],CHEMBL686755,Inhibition constant against DNA Gyrase isolated from Micrococcus luteus,B,,,BAO_0000192,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123568,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,131714,=,1,0,=,,Ki,ug ml-1,,72.0,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,Ki,ug ml-1,UO_0000274,,72.0
12669,,,1080789,[],CHEMBL686746,Inhibition constant against DNA Gyrase isolated from Escherichia coli,B,,,BAO_0000192,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123568,J Med Chem,1987.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,131714,=,1,0,=,,Ki,ug ml-1,,1.0,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,Ki,ug ml-1,UO_0000274,,1.0
12670,,,1086840,[],CHEMBL808596,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134762,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,139263,=,1,1,=,,MIC,nM,,4890.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,4.89
12671,,,1086841,[],CHEMBL840510,Antibacterial activity tested against ampicillin and erythromycin-resistant Streptococcus pneumoniae,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134762,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,139263,=,1,1,=,,MIC,nM,,19600.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,uM,UO_0000065,,19.6
12672,,,1086842,[],CHEMBL679634,Antibacterial activity tested against vancomycin-resistant Enterococcus faecalis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1134762,J Med Chem,2001.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,139263,=,1,1,=,,MIC,nM,,9800.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,uM,UO_0000065,,9.8
12673,,,1097091,[],CHEMBL686748,Inhibitory activity against Escherichia coli DNA gyrase (represented as MNEC),B,,,BAO_0000179,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126288,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,44470,=,1,0,=,,MNEC,ug ml-1,,0.5,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,MNEC,ug ml-1,UO_0000274,,0.5
12674,,,1097092,[],CHEMBL670213,In vitro for antibacterial activity against Escherichia coli 1346 (Ec(A)),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126288,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,44470,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.12
12675,,,1097093,[],CHEMBL674871,In vitro for antibacterial activity against Escherichia coli B (Ec(B)),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126288,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,44470,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.12
12676,,,1097094,[],CHEMBL670214,In vitro for antibacterial activity against Escherichia coli 1527E (Ec(C)),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126288,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,44470,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.12
12677,,,1097095,[],CHEMBL704060,In vitro for antibacterial activity against Klebsiella oxytoca 1082E,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126288,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,44470,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC,ug ml-1,UO_0000274,,0.25
12678,,,1097096,[],CHEMBL675282,In vitro for antibacterial activity against Enterobacter cloacae P99,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126288,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,44470,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.25
12679,,,1097097,[],CHEMBL764226,In vitro for antibacterial activity against Pseudomonas aeruginosa 799/61,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126288,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,44470,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
12680,,,1097098,[],CHEMBL808689,In vitro for antibacterial activity against Staphylococcus aureus 887,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126288,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,44470,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
12681,,,1097099,[],CHEMBL813152,In vitro for antibacterial activity against Staphylococcus haemolyticus 75 (quinolone-resistant),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126288,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,44470,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,64.0
12682,,,1097100,[],CHEMBL875048,In vitro for antibacterial activity against Bacillus subtilis ATCC 585369,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126288,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,44470,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,1.0
12683,,,1097101,[],CHEMBL731200,In vitro for antibacterial activity against Micrococcus luteus ATCC 8340,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1126288,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,44470,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,32.0
12684,,,1120694,[],CHEMBL802193,In vitro minimum inhibitory concentration (MIC) against Staphylococcus aureus Smith A 9537 at 37 degrees C for 18 hr,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,40173,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
12685,,,1120695,[],CHEMBL674335,In vitro minimum inhibitory concentration (MIC) against Enterococcus faecalis A 9808 at 37 degrees C for 18 h.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,40173,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
12686,,,1120696,[],CHEMBL675654,In vitro minimum inhibitory concentration (MIC) against Enterococcus faecium A 24885 at 37 degrees C for 18 h.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,40173,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,8.0
12687,,,1120697,[],CHEMBL674474,In vitro minimum inhibitory concentration (MIC) against Escherichia coli A 15119 at 37 degrees C for 18 h.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,40173,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.13
12688,,,1120698,[],CHEMBL703679,In vitro minimum inhibitory concentration (MIC) against Klebsiella pneumoniae A 9664 at 37 degrees C for 18 h.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,40173,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
12689,,,1120699,[],CHEMBL857931,In vitro minimum inhibitory concentration (MIC) against Enterobacter cloacae A 9656 at 37 degrees C for 18 h.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,40173,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.06
12690,,,1120700,[],CHEMBL732722,In vitro minimum inhibitory concentration (MIC) against Morganella morganii A 15153 at 37 degrees C for 18 h.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,40173,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.015
12691,,,1120701,[],CHEMBL803357,In vitro minimum inhibitory concentration (MIC) against Serratia marcescens A 20019 at 37 degrees C for 18 hr,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,40173,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.13
12692,,,1120702,[],CHEMBL755256,In vitro minimum inhibitory concentration (MIC) against Pseudomonas aeruginosa A 9843 at 37 degree C for 18 h,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,40173,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
12693,,,1120703,[],CHEMBL795173,Efficacy on systematic infections against Staphylococcus aureus Smith A 9537 after oral administration in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,40173,=,1,0,=,,PD50,mg kg-1,,1.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PD50,mg kg-1,UO_0000308,,1.9
12694,,,1120704,[],CHEMBL755261,Efficacy on systematic infections against Pseudomonas aeruginosa A 9843 after oral administration in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,40173,=,1,0,=,,PD50,mg kg-1,,12.6,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,PD50,mg kg-1,UO_0000308,,12.6
12695,,,1120705,[],CHEMBL676458,Efficacy on systematic infections against Escherichia coli A 15119 after oral administration in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,40173,=,1,0,=,,PD50,mg kg-1,,13.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,13.0
12696,,,1120706,[],CHEMBL701270,Efficacy on systematic infections against Klebsiella pneumoniae A 9664 after oral administration in mice,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124759,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,40173,=,1,0,=,,PD50,mg kg-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,PD50,mg kg-1,UO_0000308,,8.0
12697,,,1158816,[],CHEMBL679918,Activity against Enterobacter aerogenes,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1136155,Bioorg Med Chem Lett,2003.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,166637,=,1,0,=,,CMI,mg l-1,,0.1,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,CMI,mg l-1,,,0.1
12698,,,1158817,[],CHEMBL876624,Bioavailability,A,,,BAO_0003042,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1136155,Bioorg Med Chem Lett,2003.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,166637,=,1,1,=,,F,%,,62.99,CHEMBL612558,,ADMET,,,,F,%,UO_0000187,,62.99
12699,,,1175443,[],CHEMBL679742,Minimum inhibitory concentration (MIC) against gram negative bacteria Enterobacter cloacae MA-2646.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231123,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.1
12700,,,1175444,[],CHEMBL677147,Minimum inhibitory concentration (MIC) against gram negative bacteria Escherichia coli Vogel.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231123,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
12701,,,1175445,[],CHEMBL704959,Minimum inhibitory concentration (MIC) against gram negative bacteria Klebsiella pneumoniae MGH-2.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231123,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
12702,,,1175446,[],CHEMBL765170,Minimum inhibitory concentration (MIC) against gram negative bacteria Prot. rettgeri M-1771.,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231123,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.025
12703,,,1175447,[],CHEMBL769275,Minimum inhibitory concentration (MIC) against gram negative bacteria Pseudomonas aeruginosa UI-18.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231123,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
12704,,,1175448,[],CHEMBL677146,Minimum inhibitory concentration (MIC) against gram negative bacteria Escherichia coli H-560.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231123,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.1
12705,,,1175449,[],CHEMBL804896,Minimum inhibitory concentration (MIC) against gram positive bacteria Staphylococcus aureus H-228.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231123,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.8
12706,,,1175450,[],CHEMBL804897,Minimum inhibitory concentration (MIC) against gram positive bacteria Staphylococcus aureus UC-76.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231123,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
12707,,,1175451,[],CHEMBL809011,Minimum inhibitory concentration (MIC) against gram positive bacteria Streptococcus faecalis MGH-2.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231123,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.6
12708,,,1175452,[],CHEMBL809012,Minimum inhibitory concentration (MIC) against gram positive bacteria Streptococcus pneumoniae SV-1.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231123,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.6
12709,,,1175453,[],CHEMBL809013,Minimum inhibitory concentration (MIC) against gram positive bacteria Streptococcus pyogenes C-203.,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,231123,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.8
12710,,,1175454,[],CHEMBL672335,In vivo efficacy in mouse protection test in Escherichia coli Vogel dose administered orally by gavage.,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,231123,=,1,0,=,,PD50,mg kg-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,4.0
12711,,,1175455,[],CHEMBL672334,In vivo efficacy in mouse protection test in Escherichia coli Vogel administered by subcutaneous injection.,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,231123,=,1,0,=,,PD50,mg kg-1,,0.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,PD50,mg kg-1,UO_0000308,,0.6
12712,,,1175456,[],CHEMBL804730,In vivo efficacy (orally) against Streptococcus pyogenes C-203 in mouse protection test,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,231123,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PD50,mg kg-1,UO_0000308,,100.0
12713,,,1175457,[],CHEMBL804729,In vivo efficacy (s.c.) against Streptococcus pyogenes C-203 in mouse protection test,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,231123,=,1,0,=,,PD50,mg kg-1,,45.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PD50,mg kg-1,UO_0000308,,45.0
12714,,,1175458,[],CHEMBL809846,In vivo efficacy (orally) against Streptococcus pneumoniae SV-1 in mouse protection test,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,231123,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,PD50,mg kg-1,UO_0000308,,100.0
12715,,,1175459,[],CHEMBL809845,In vivo efficacy (s.c.) against Streptococcus pneumoniae SV-1 in mouse protection test,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,231123,=,1,0,=,,PD50,mg kg-1,,150.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,PD50,mg kg-1,UO_0000308,,150.0
12716,,,1175460,[],CHEMBL769274,In vivo efficacy (orally) against Pseudomonas aeruginosa in mouse protection test,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,231123,=,1,0,=,,PD50,mg kg-1,,76.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,PD50,mg kg-1,UO_0000308,,76.0
12717,,,1175461,[],CHEMBL769273,In vivo efficacy (s.c.) against Pseudomonas aeruginosa in mouse protection test,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,231123,=,1,0,=,,PD50,mg kg-1,,11.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,PD50,mg kg-1,UO_0000308,,11.0
12718,,,1175462,[],CHEMBL739992,Maximum tolerance dose was measured for phototoxic skin reaction by po administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,231123,=,1,0,=,,MTD,mg kg-1,,300.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,MTD,mg kg-1,UO_0000308,,300.0
12719,,,1175463,[],CHEMBL739994,Maximum tolerance dose was measured for phototoxic skin reaction by sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,231123,=,1,0,=,,MTD,mg kg-1,,300.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,MTD,mg kg-1,UO_0000308,,300.0
12720,,,1175464,[],CHEMBL663666,Number of mice which show positive phototoxic reaction in 5 mice at peroral dose,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,231123,=,1,0,=,,No. of pos rxns,,,0.0,CHEMBL612545,,Unchecked,,,,No. of pos rxns,,,,0.0
12721,,,1175465,[],CHEMBL663667,Number of mice which show positive phototoxic reaction in 5 mice at subcutaneous dose,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,231123,=,1,0,=,,No. of pos rxns,,,5.0,CHEMBL612545,,Unchecked,,,,No. of pos rxns,,,,5.0
12722,,,1175466,[],CHEMBL663663,Days of the first positive reaction in depleted mice.,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,231123,=,1,0,=,,Day of first positve reaction,,,0.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Day of first positve reaction,,,,0.0
12723,,,1175467,[],CHEMBL663663,Days of the first positive reaction in depleted mice.,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,231123,=,1,0,=,,Day of first positve reaction,,,3.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Day of first positve reaction,,,,3.0
12724,,,1175468,[],CHEMBL722856,Dose required to induce phototoxic reaction in 50% of mice by probit method at different dosage forms.,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,231123,>,1,0,>,,PTD50,mg kg-1,,300.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PTD50,mg kg-1,UO_0000308,,300.0
12725,,,1175469,[],CHEMBL722856,Dose required to induce phototoxic reaction in 50% of mice by probit method at different dosage forms.,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,231123,=,1,0,=,,PTD50,mg kg-1,,172.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PTD50,mg kg-1,UO_0000308,,172.0
12726,,,1175470,[],CHEMBL727080,Dose which has no effect to induce phototoxic reaction in 50% of mice by probit method.,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,231123,=,1,0,=,,No effect dose,mg kg-1,,300.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,No effect dose,mg kg-1,UO_0000308,,300.0
12727,,,1175471,[],CHEMBL727080,Dose which has no effect to induce phototoxic reaction in 50% of mice by probit method.,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1125291,J Med Chem,1992.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,231123,=,1,0,=,,No effect dose,mg kg-1,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,No effect dose,mg kg-1,UO_0000308,,100.0
12728,,,1203628,[],CHEMBL810989,In vitro antibacterial activity against Staphylococcus aureus ATCC 6538P,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138463,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
12729,,,1203629,[],CHEMBL858070,In vitro antibacterial activity against Staphylococcus aureus CMX 686B,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138463,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
12730,,,1203630,[],CHEMBL881264,In vitro antibacterial activity against Staphylococcus epidermidis 3519,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138463,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.56
12731,,,1203631,[],CHEMBL813856,In vitro antibacterial activity against Streptococcus faecium ATCC 8043,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138463,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.78
12732,,,1203632,[],CHEMBL810786,In vitro antibacterial activity against Streptococcus pyogenes 930,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138463,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,3.1
12733,,,1203633,[],CHEMBL676164,In vitro antibacterial activity against Escherichia coli Juhl,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138463,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.1
12734,,,1203634,[],CHEMBL678425,In vitro antibacterial activity against Enterobacter aerogenes ATCC 13048,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138463,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.2
12735,,,1203635,[],CHEMBL704187,In vitro antibacterial activity against Klebsiella pneumoniae 8045,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138463,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.1
12736,,,1203636,[],CHEMBL772488,In vitro antibacterial activity against Pseudomonas aeruginosa 5007,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138463,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.39
12737,,,1203637,[],CHEMBL772489,In vitro antibacterial activity against Pseudomonas aeruginosa K799/WT,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138463,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.39
12738,,,1203638,[],CHEMBL639047,In vitro antibacterial activity against Acinetobacter species CMX669,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123369,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,138463,=,1,1,=,,MIC,ug.mL-1,,6.2,CHEMBL614427,Acinetobacter sp.,Acinetobacter sp.,472.0,,,MIC,ug ml-1,UO_0000274,,6.2
12739,,,1214898,[],CHEMBL811498,In vitro antibacterial activity against Staphylococcus aureus FDA 2029P JC-1,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184742,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
12740,,,1214899,[],CHEMBL804400,In vitro antibacterial activity against Staphylococcus epidermidis IAM 1296,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184742,=,1,1,=,,MIC,ug.mL-1,,3.13,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,3.13
12741,,,1214900,[],CHEMBL650442,In vitro antibacterial activity against Bacillus subtilis ATCC 6633,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184742,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.39
12742,,,1214901,[],CHEMBL857118,In vitro antibacterial activity against Escherichia coli NHJ JC-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184742,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.2
12743,,,1214902,[],CHEMBL703023,In vitro antibacterial activity against Klebsiella pneumoniae PCI-602,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184742,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.1
12744,,,1214903,[],CHEMBL771778,In vitro antibacterial activity against Proteus vulgaris OX-19,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184742,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.1
12745,,,1214904,[],CHEMBL805695,In vitro antibacterial activity against Salmonella Typhimurium IID 971,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184742,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.05
12746,,,1214905,[],CHEMBL805411,In vitro antibacterial activity against Serratia,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184742,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL614592,Serratia,Serratia,613.0,,,MIC,ug ml-1,UO_0000274,,0.39
12747,,,1214906,[],CHEMBL764322,In vitro antibacterial activity against Pseudomonas aeruginosa IFO 3445,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184742,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.56
12748,,,1214907,[],CHEMBL809217,In vitro antibacterial activity against Streptococcus aureus IID 803 -,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184742,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.56
12749,,,1214908,[],CHEMBL809216,In vitro antibacterial activity against Streptococcus aureus IID 803 (po),F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,184742,=,1,1,=,,ED50,mg.kg-1,,225.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,225.0
12750,,,1214909,[],CHEMBL857115,In vivo antibacterial activity against Escherichia coli KC-14,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184742,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.2
12751,,,1214910,[],CHEMBL676897,In vivo antibacterial activity against Escherichia coli KC-14 (po),F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,184742,=,1,1,=,,ED50,mg.kg-1,,5.82,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,5.82
12752,,,1214911,[],CHEMBL740239,Acute toxicity on oral administration in mice,T,,,BAO_0002117,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,184742,>,1,1,>,,LD50,mg.kg-1,,4000.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,LD50,mg kg-1,UO_0000308,,4000.0
12753,,,1214912,[],CHEMBL740238,Acute toxicity on intravenous injection in in mice,T,,,BAO_0002117,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,184742,=,1,1,=,,LD50,mg.kg-1,,314.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,LD50,mg kg-1,UO_0000308,,314.0
12754,,,1214913,[],CHEMBL632054,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,A,,,BAO_0002752,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184742,=,1,0,=,,Concentration,ug ml-1,,4.14,CHEMBL612558,,ADMET,,,,Concentration,ug ml-1,UO_0000274,,4.14
12755,,,1214914,[],CHEMBL631181,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,F,,,BAO_0002752,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184742,=,1,0,=,,Concentration,ug ml-1,,2.8,CHEMBL612558,,ADMET,,,,Concentration,ug ml-1,UO_0000274,,2.8
12756,,,1214915,[],CHEMBL632052,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,F,,,BAO_0002752,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184742,=,1,0,=,,Concentration,ug ml-1,,1.09,CHEMBL612558,,ADMET,,,,Concentration,ug ml-1,UO_0000274,,1.09
12757,,,1214916,[],CHEMBL632053,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,F,,,BAO_0002752,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184742,=,1,0,=,,Concentration,ug ml-1,,0.47,CHEMBL612558,,ADMET,,,,Concentration,ug ml-1,UO_0000274,,0.47
12758,,,1214917,[],CHEMBL632055,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,F,,,BAO_0002752,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184742,=,1,0,=,,Concentration,ug ml-1,,1.41,CHEMBL612558,,ADMET,,,,Concentration,ug ml-1,UO_0000274,,1.41
12759,,,1214918,[],CHEMBL632055,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,F,,,BAO_0002752,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184742,=,1,0,=,,Concentration,ug ml-1,,1.27,CHEMBL612558,,ADMET,,,,Concentration,ug ml-1,UO_0000274,,1.27
12760,,,1214919,[],CHEMBL632055,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,F,,,BAO_0002752,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184742,=,1,0,=,,Concentration,ug ml-1,,0.73,CHEMBL612558,,ADMET,,,,Concentration,ug ml-1,UO_0000274,,0.73
12761,,,1214920,[],CHEMBL632055,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,F,,,BAO_0002752,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,184742,=,1,0,=,,Concentration,ug ml-1,,0.23,CHEMBL612558,,ADMET,,,,Concentration,ug ml-1,UO_0000274,,0.23
12762,,,1214921,"[{'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '4.0'}]",CHEMBL627729,AUC value (0-4 hr),A,,,BAO_0002120,BAO_0000366,cell-free format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,184742,=,1,1,=,,AUC,ng.hr.mL-1,,6500.0,CHEMBL612558,,ADMET,,,,AUC,ug hr ml-1,,,6.5
12763,,,1214922,"[{'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '4.0'}]",CHEMBL627729,AUC value (0-4 hr),A,,,BAO_0002120,BAO_0000366,cell-free format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1124996,J Med Chem,1990.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,184742,=,1,1,=,,AUC,ng.hr.mL-1,,2300.0,CHEMBL612558,,ADMET,,,,AUC,ug hr ml-1,,,2.3
12764,,,1253624,[],CHEMBL857198,MIC at which cleaved DNA (linear) is observed at an intensity relative to oxolinic acid at 10 ug/mL by using Gyrase Induced DNA-Cleavage assay,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249250,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
12765,,,1253625,[],CHEMBL688001,Inhibitory concentration in supercoiling inhibition Escherichia coli DNA gyrase assay,B,,,BAO_0000190,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249250,=,1,1,=,,IC50,ug.mL-1,,5.5,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,I50,ug ml-1,UO_0000274,,5.5
12766,,,1253626,[],CHEMBL675494,Antibacterial activity against Escherichia coli (H560),F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249250,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,MIC,ug ml-1,UO_0000274,,0.1
12767,,,1253627,[],CHEMBL675496,Antibacterial activity against Escherichia coli (vogel),F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249250,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,MIC,ug ml-1,UO_0000274,,0.025
12768,,,1253628,[],CHEMBL705833,Antibacterial activity against Klebsiella pneumonia (MGH-2),F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249250,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,MIC,ug ml-1,UO_0000274,,0.05
12769,,,1253629,[],CHEMBL770156,Antibacterial activity against Pseudomonas aeruginosa (UI-18),F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249250,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,MIC,ug ml-1,UO_0000274,,0.2
12770,,,1253630,[],CHEMBL809476,Antibacterial activity against Staphylococcus aureus (H228),F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249250,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,MIC,ug ml-1,UO_0000274,,0.8
12771,,,1253631,[],CHEMBL809331,Antibacterial activity against Streptococcus pneumoniae (SV-1),F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1123417,J Med Chem,1986.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,249250,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL3396,Homo sapiens,DNA topoisomerase II beta,9606.0,,,MIC,ug ml-1,UO_0000274,,1.6
12772,,,1274526,[],CHEMBL686514,Percent relaxation using isolated guinea pig trachea.,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131357,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,280434,=,1,0,=,,Relaxation,%,,0.0,CHEMBL369,Cavia porcellus,Cavia porcellus,10141.0,,,Relaxation,%,UO_0000187,,0.0
12773,,Not Determined,1274527,[],CHEMBL692841,pD2 value (pD2 = -log EC50) was calculated using guinea pig trachea; ND means not determined,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1131357,Bioorg Med Chem Lett,1998.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,280434,,1,0,,,pD2,,,,CHEMBL369,Cavia porcellus,Cavia porcellus,10141.0,,,pD2,,,,
12774,,,1495734,[],CHEMBL838962,Dissociation constant (pKa) was determined,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,386218,=,1,0,=,,pKa1,,,6.54,CHEMBL2362975,,No relevant target,,,,pKa1,,,,6.54
12775,,,1495735,[],CHEMBL838964,Dissociation constant (pKa) was determined,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,386218,=,1,0,=,,pKa2,,,8.8,CHEMBL2362975,,No relevant target,,,,pKa2,,,,8.8
12776,,,1495736,[],CHEMBL876455,Partition coefficient (logD2.0),P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,386218,=,1,1,=,,LogD,,,-1.46,CHEMBL2362975,,No relevant target,,,,logD,,,,-1.46
12777,,,1495737,[],CHEMBL827011,Partition coefficient (logD7.4),P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,386218,=,1,1,=,,LogD,,,-1.0,CHEMBL2362975,,No relevant target,,,,logD,,,,-1.0
12778,,,1508498,[],CHEMBL830559,In vitro antibacterial activity against Staphylococcus aureus Smith,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1144355,J Med Chem,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,390250,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
12779,,,1508499,[],CHEMBL831513,In vitro antibacterial activity against Streptococcus pneumoniae type III,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1144355,J Med Chem,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,390250,=,1,1,=,,MIC,ug.mL-1,,3.13,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,3.13
12780,,,1508500,[],CHEMBL831859,In vitro antibacterial activity against Escherichia coli NIHJ JC-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1144355,J Med Chem,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,390250,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
12781,,,1508501,[],CHEMBL831394,In vitro antibacterial activity against Pseudomonas aeruginosa IID1210,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1144355,J Med Chem,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,390250,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.56
12782,,,1611612,[],CHEMBL871611,In vitro minimum inhibitory concentration against Bacillus subtilis upon incubation at 37 degree C for 16 to 24 h,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1140385,J Med Chem,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,403412,=,1,1,=,,MIC,ug.mL-1,,0.313,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.313
12783,,,1611613,[],CHEMBL871614,In vitro minimum inhibitory concentration against Staphylococcus aureus upon incubation at 37 degree C for 16 to 24 hr by dissolving in DMSO (1%),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1140385,J Med Chem,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,403412,=,1,1,=,,MIC,ug.mL-1,,0.625,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.625
12784,,,1611614,[],CHEMBL871616,In vitro minimum inhibitory concentration against Staphylococcus aureus (Smith) upon incubation at 37 degree C for 16 to 24 hr by dissolving in DMSO (1%),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1140385,J Med Chem,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,403412,=,1,1,=,,MIC,ug.mL-1,,0.156,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.156
12785,,,1611615,[],CHEMBL871622,In vitro minimum inhibitory concentration against Methicillin-resistant Staphylococcus aureus upon incubation at 37 degree C for 16 to 24 hr by dissolving in DMSO (1%),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1140385,J Med Chem,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,403412,=,1,1,=,,MIC,ug.mL-1,,40.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,40.0
12786,,,1611616,[],CHEMBL871613,In vitro minimum inhibitory concentration against Enterococcus faecalis upon incubation at 37 degree C for 16 to 24 hr by dissolving in DMSO (1%),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1140385,J Med Chem,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,403412,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,2.5
12787,,,1611617,[],CHEMBL871612,In vitro minimum inhibitory concentration against Enterococcus fecium upon incubation at 37 degree C for 16 to 24 hr by dissolving in DMSO (1%),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1140385,J Med Chem,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,403412,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,10.0
12788,,,1611618,[],CHEMBL871621,In vitro minimum inhibitory concentration against Vancomycin resistant Enterococci faecium upon incubation at 37 degree C for 16 to 24 hr by dissolving in DMSO (1%),F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1140385,J Med Chem,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,403412,=,1,1,=,,MIC,ug.mL-1,,80.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,80.0
12789,,,1611619,[],CHEMBL884060,Serum effect on MIC against Staphylococcus aureus (Smith) as ratio of MIC value in presence and absence of 50% fetal calf serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1140385,J Med Chem,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,403412,=,1,0,=,,MIC+/MIC-,,,0.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC+/MIC-,,,,0.4
12790,,,1611620,[],CHEMBL884059,Serum effect on MIC of compound was measured against Enterococcus faecalis as ratio of MIC value in presence and absence of 50% fetal calf serum,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1140385,J Med Chem,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,403412,=,1,0,=,,MIC+/MIC-,,,2.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC+/MIC-,,,,2.2
12791,,,1614697,[],CHEMBL884142,Minimum inhibitory concentration against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142848,Bioorg Med Chem Lett,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,404163,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
12792,,,1614698,[],CHEMBL884143,Minimum inhibitory concentration against Staphylococcus epidermidis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142848,Bioorg Med Chem Lett,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,404163,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
12793,,,1614699,[],CHEMBL884139,Minimum inhibitory concentration against Bacillus subtilis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142848,Bioorg Med Chem Lett,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,404163,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.06
12794,,,1614700,[],CHEMBL884140,Minimum inhibitory concentration against Klebsiella pneumoniae,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142848,Bioorg Med Chem Lett,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,404163,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
12795,,,1614701,[],CHEMBL884141,Minimum inhibitory concentration against Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142848,Bioorg Med Chem Lett,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,404163,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
12796,,,1614702,[],CHEMBL883206,Minimum inhibitory concentration against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142848,Bioorg Med Chem Lett,2005.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,404163,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
12797,,,1667310,[],CHEMBL864624,Antibacterial activity against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1148591,J Med Chem,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,417967,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
12798,,,1667315,[],CHEMBL864625,Antibacterial activity against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1148591,J Med Chem,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,417967,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
12799,,,1667320,[],CHEMBL869436,Inhibition of DNA gyrase supercoiling in Escherichia coli ATCC 25922,B,,,BAO_0000190,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1148591,J Med Chem,2006.0,"{'bei': '19.48', 'le': '0.37', 'lle': '4.95', 'sei': '8.34'}",CHEMBL9,NORFLOXACIN,CHEMBL9,6.22,0,http://www.openphacts.org/units/Nanomolar,417967,=,1,1,=,,IC50,nM,,600.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,uM,UO_0000065,,0.6
12800,,,1667325,[],CHEMBL854373,Inhibition of topoisomerase 4 decatenation in Staphylococcus aureus ATCC 29213,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1148591,J Med Chem,2006.0,"{'bei': '17.09', 'le': '0.32', 'lle': '4.19', 'sei': '7.32'}",CHEMBL9,NORFLOXACIN,CHEMBL9,5.46,0,http://www.openphacts.org/units/Nanomolar,417967,=,1,1,=,,IC50,nM,,3500.0,CHEMBL4088,Staphylococcus aureus,Topoisomerase IV subunit A,1280.0,,,IC50,uM,UO_0000065,,3.5
12801,,Not Active,1683699,[],CHEMBL861887,Binding affinity to Bacillus subtilis DNA polymerase3C,B,,,BAO_0000192,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,428199,,1,0,,,Ki,,,,CHEMBL3897,Bacillus subtilis (strain 168),DNA polymerase III,224308.0,,,Ki,,,,
12802,,,1683726,[],CHEMBL862001,Antibacterial activity against Bacillus subtilis BD54,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428199,=,1,1,=,,MIC,ug.mL-1,,0.313,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.313
12803,,,1683753,[],CHEMBL862003,Antibacterial activity against Staphylococcus aureus 25293,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428199,=,1,1,=,,MIC,ug.mL-1,,0.625,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.625
12804,,,1683781,[],CHEMBL862058,Antibacterial activity against Staphylococcus aureus smith,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428199,=,1,1,=,,MIC,ug.mL-1,,0.156,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.156
12805,,,1683807,[],CHEMBL862059,Antibacterial activity against methicillin resistant Staphylococcus aureus MRSA 1094,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428199,=,1,1,=,,MIC,ug.mL-1,,40.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,40.0
12806,,,1683834,[],CHEMBL862060,Antibacterial activity against Enterococcus faecalis 29212,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428199,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,2.5
12807,,,1683854,[],CHEMBL862061,Antibacterial activity against Enterococcus faecium 19434,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428199,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,10.0
12808,,,1683888,[],CHEMBL862062,Antibacterial activity against Vancomycin resistant Enterococcus faecium VRE 700802,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428199,=,1,1,=,,MIC,ug.mL-1,,80.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,80.0
12809,,,1683915,[],CHEMBL862063,Antibacterial activity against Escherichia coli J53,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138117,J Med Chem,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428199,=,1,1,=,,MIC,ug.mL-1,,1.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.25
12810,,,1735346,[],CHEMBL864791,Antibacterial activity against Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1137433,Bioorg Med Chem Lett,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,500059,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.78
12811,,,1735347,[],CHEMBL862937,Antibacterial activity against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1137433,Bioorg Med Chem Lett,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,500059,=,1,1,=,,MIC,ug.mL-1,,0.36,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.36
12812,,,1735348,[],CHEMBL862936,Antibacterial activity against Klebsiella pneumoniae,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1137433,Bioorg Med Chem Lett,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,500059,=,1,1,=,,MIC,ug.mL-1,,0.36,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.36
12813,,,1735349,[],CHEMBL862935,Antibacterial activity against Streptococcus faecalis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1137433,Bioorg Med Chem Lett,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,500059,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.78
12814,,,1735350,[],CHEMBL862934,Antibacterial activity against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1137433,Bioorg Med Chem Lett,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,500059,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.3
12815,,,1738058,[],CHEMBL870495,Antibacterial activity against methicillin-resistant Staphylococcus aureus 2 by agar-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512271,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
12816,,,1738061,[],CHEMBL868689,Antibacterial activity against methicillin-resistant Staphylococcus aureus 1 by agar-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512271,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
12817,,,1738068,[],CHEMBL868687,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 by agar-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512271,=,1,1,=,,MIC,ug.mL-1,,3.13,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.13
12818,,,1738069,[],CHEMBL868686,Antibacterial activity against Klebsiella pneumoniae ATCC 10031 by agar-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512271,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.049
12819,,,1738070,[],CHEMBL868685,Antibacterial activity against Escherichia coli ATCC 8739 by agar-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512271,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.049
12820,,,1738072,[],CHEMBL868681,Antibacterial activity against Bacillus subtilis ATCC 6633 by agar-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512271,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.049
12821,,,1738074,[],CHEMBL868684,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 by agar-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512271,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.78
12822,,,1738075,[],CHEMBL868678,Antibacterial activity against Staphylococcus aureus ATCC 6538p by agar-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512271,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
12823,,,1826981,[],CHEMBL909713,Bacteriostatic activity against Escherichia coli DM4100 in aerobic condition,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625566,=,1,1,=,,MIC,ug.mL-1,,0.075,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.075
12824,,,1826984,[],CHEMBL910810,Bacteriostatic activity against Escherichia coli DM4100 in anaerobic condition,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625566,=,1,1,=,,MIC,ug.mL-1,,0.075,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.075
12825,,Not Active,1826989,[],CHEMBL910814,Bactericidal activity against Escherichia coli DM4100 in the presence of chloramphenicol,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,625566,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
12826,,Active,1826992,[],CHEMBL910815,Bactericidal activity in Escherichia coli KD1373 containing parC mutation in anerobic condition,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,625566,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
12827,,Active,1826993,[],CHEMBL910816,Bactericidal activity in Escherichia coli KD2750 containing gyrA resistant mutation in anerobic condition,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,625566,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
12828,,Not Active,1826994,[],CHEMBL910817,Bactericidal activity in Escherichia coli KD2329 containing gyrA-parC mutation,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,625566,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
12829,,Active,1829145,[],CHEMBL910813,Bactericidal activity against Escherichia coli DM4100 in anaerobic condition,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,625566,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
12830,,Active,1832969,[],CHEMBL910811,Bactericidal activity against Escherichia coli DM4100 in aerobic condition,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,625566,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
12831,,,1834052,[],CHEMBL855355,Antibacterial activity against Streptococcus suis ATCC 43765 after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,4.0
12832,,,1834056,[],CHEMBL855356,Antibacterial activity against Streptococcus suis BB1001 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,2.0
12833,,,1834060,[],CHEMBL855357,Antibacterial activity against Streptococcus suis BB1002 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,2.0
12834,,,1834064,[],CHEMBL855358,Antibacterial activity against Streptococcus suis BB1003 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,4.0
12835,,,1834068,[],CHEMBL855359,Antibacterial activity against Streptococcus suis BB1004 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,2.0
12836,,,1834072,[],CHEMBL855360,Antibacterial activity against Streptococcus suis BB1005 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,4.0
12837,,,1834076,[],CHEMBL855361,Antibacterial activity against Streptococcus suis BB1006 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,32.0
12838,,,1834080,[],CHEMBL855362,Antibacterial activity against Streptococcus suis BB1007 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,16.0
12839,,,1834084,[],CHEMBL855363,Antibacterial activity against Streptococcus suis BB1008 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
12840,,,1834088,[],CHEMBL855364,Antibacterial activity against Streptococcus suis BB1009 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,32.0
12841,,,1834092,[],CHEMBL855365,Antibacterial activity against Streptococcus suis BB1010 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
12842,,,1834096,[],CHEMBL855366,Antibacterial activity against Streptococcus suis BB1011 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,32.0
12843,,,1834100,[],CHEMBL855367,Antibacterial activity against Streptococcus suis BB1012 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
12844,,,1834104,[],CHEMBL855368,Antibacterial activity against Streptococcus suis BB1013 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
12845,,,1834108,[],CHEMBL855369,Antibacterial activity against Streptococcus suis BB1014 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
12846,,,1834112,[],CHEMBL855370,Antibacterial activity against Streptococcus suis BB1015 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
12847,,,1834116,[],CHEMBL855371,Antibacterial activity against Streptococcus suis BB1016 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
12848,,,1834120,[],CHEMBL854309,Antibacterial activity against Streptococcus suis BB1017 isolate after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,,MIC,ug ml-1,UO_0000274,,64.0
12849,,Active,1834538,[],CHEMBL910812,Bactericidal activity against Escherichia coli DM4100 in saline,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,625566,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
12850,,,1847300,[],CHEMBL918716,Antibacterial activity against Staphylococcus aureus SA1199B overexpressing NorA at 5 ug by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1142063,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,631991,=,1,1,=,,IZ,mm,,27.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,27.0
12851,,,1867046,[],CHEMBL904486,Antimicrobial activity against Escherichia coli AG100 mutant with argE3 thi-3 rpsL xyl mtl supE44 genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
12852,,,1867051,[],CHEMBL904487,Antimicrobial activity against Escherichia coli M013 mutant with AG100 delta-(lon-hupB-ppiD) dupIS5 genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.13
12853,,,1867063,[],CHEMBL904488,Antimicrobial activity against Escherichia coli M043 mutant with AG100 lon4::IS186 marR::IS2 genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.38
12854,,,1867068,[],CHEMBL904489,Antimicrobial activity against Escherichia coli M044 mutant with AG100 lon4::IS186 marR::IS genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
12855,,,1867080,[],CHEMBL904490,Antimicrobial activity against Escherichia coli M064 mutant with AG100 lon1::IS186 acrR::IS genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.19
12856,,,1867085,[],CHEMBL904491,Antimicrobial activity against Escherichia coli M073 mutant with AG100 lon2::IS186 acrR::IS5 genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.19
12857,,,1867090,[],CHEMBL904492,Antimicrobial activity against Escherichia coli M074 mutant with AG100 lon2::IS186 acrR::IS genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.19
12858,,,1867102,[],CHEMBL904493,Antimicrobial activity against Escherichia coli M083 mutant with AG100 lon4::IS186 acrR::IS1 genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
12859,,,1867107,[],CHEMBL904494,Antimicrobial activity against Escherichia coli M084 mutant AG100 lon4::IS186 genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.13
12860,,,1867119,[],CHEMBL904495,Antimicrobial activity against Escherichia coli M093 mutant with AG100 lon3::IS186 acrR::IS1 genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
12861,,,1867124,[],CHEMBL904496,Antimicrobial activity against Escherichia coli M103 mutant with AG100 lon3::IS186 acrR-acrAB genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
12862,,,1867129,[],CHEMBL904497,Antimicrobial activity against Escherichia coli M104 mutant with AG100 dupIS3 genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
12863,,,1867141,[],CHEMBL904498,Antimicrobial activity against Escherichia coli M114 mutant with AG100 lon4::IS186 marR::IS2 genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.38
12864,,,1867146,[],CHEMBL904499,Antimicrobial activity against Escherichia coli M124 mutant with AG100 lon4::IS186 acrR::IS genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
12865,,,1867170,[],CHEMBL904500,Antimicrobial activity against Escherichia coli AG112 mutant with AG100 marR genotype,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.38
12866,,,1867174,[],CHEMBL904501,Antimicrobial activity against Escherichia coli AG112 mutant with marR genotype after 250 generations in 5 ug/ml presence of tetracycline,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
12867,,,1867178,[],CHEMBL904502,Antimicrobial activity against Escherichia coli AG112 mutant with marR genotype after 125 generations in absence of tetracycline,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.75
12868,,Active,1868733,[],CHEMBL920177,Antimicrobial activity against Pseudomonas aeruginosa P21.21 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12869,,Active,1868744,[],CHEMBL920178,Antimicrobial activity against Pseudomonas aeruginosa 65.18-1 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12870,,Active,1868753,[],CHEMBL920179,Antimicrobial activity against Pseudomonas aeruginosa 65.18-2 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12871,,Active,1868762,[],CHEMBL920180,Antimicrobial activity against Pseudomonas aeruginosa 65.18-3 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12872,,Active,1868772,[],CHEMBL920181,Antimicrobial activity against Pseudomonas aeruginosa 65.18-4 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12873,,Active,1868782,[],CHEMBL920182,Antimicrobial activity against Pseudomonas aeruginosa P21.23 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12874,,Active,1868793,[],CHEMBL920183,Antimicrobial activity against Pseudomonas aeruginosa IA5 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12875,,Active,1868804,[],CHEMBL920184,Antimicrobial activity against Pseudomonas aeruginosa IC7 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12876,,Active,1868815,[],CHEMBL920186,Antimicrobial activity against Pseudomonas aeruginosa 65.33-1 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12877,,Active,1868825,[],CHEMBL920187,Antimicrobial activity against Pseudomonas aeruginosa 65.33-2 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12878,,Active,1868834,[],CHEMBL920188,Antimicrobial activity against Pseudomonas aeruginosa 65.33-3 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12879,,Active,1868842,[],CHEMBL920189,Antimicrobial activity against Pseudomonas aeruginosa 65.33-4 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12880,,Active,1868851,[],CHEMBL920190,Antimicrobial activity against Pseudomonas aeruginosa 65.36-1 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12881,,Active,1868860,[],CHEMBL920191,Antimicrobial activity against Pseudomonas aeruginosa 65.36-2 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12882,,Active,1868870,[],CHEMBL920192,Antimicrobial activity against Pseudomonas aeruginosa 65.36-3 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12883,,Active,1868918,[],CHEMBL920193,Antimicrobial activity against Pseudomonas aeruginosa 65.36-4 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12884,,Active,1868929,[],CHEMBL920195,Antimicrobial activity against Pseudomonas aeruginosa 65.38-2 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12885,,Active,1868939,[],CHEMBL912018,Antimicrobial activity against Pseudomonas aeruginosa 65.38-3 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12886,,Active,1868948,[],CHEMBL912019,Antimicrobial activity against Pseudomonas aeruginosa 65.38-4 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12887,,Active,1868964,[],CHEMBL920194,Antimicrobial activity against Pseudomonas aeruginosa 65.38-1 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12888,,Active,1869018,[],CHEMBL912020,Antimicrobial activity against Pseudomonas aeruginosa 1A9 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12889,,Active,1869029,[],CHEMBL912021,Antimicrobial activity against Pseudomonas aeruginosa 1B9 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12890,,Active,1869121,[],CHEMBL912022,Antimicrobial activity against Pseudomonas aeruginosa 1C9 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12891,,Active,1869128,[],CHEMBL913069,Antimicrobial activity against Pseudomonas aeruginosa 2A1 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12892,,Active,1869145,[],CHEMBL913070,Antimicrobial activity against Pseudomonas aeruginosa 2C1 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12893,,Active,1869148,[],CHEMBL913071,Antimicrobial activity against Pseudomonas aeruginosa 2A2 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12894,,Active,1869159,[],CHEMBL913072,Antimicrobial activity against Pseudomonas aeruginosa 2C2 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12895,,Active,1869169,[],CHEMBL913073,Antimicrobial activity against Pseudomonas aeruginosa 2A3 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12896,,Active,1869180,[],CHEMBL913074,Antimicrobial activity against Pseudomonas aeruginosa 2A5 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12897,,Active,1869231,[],CHEMBL913075,Antimicrobial activity against Pseudomonas aeruginosa 2B5 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12898,,Active,1869245,[],CHEMBL913076,Antimicrobial activity against Pseudomonas aeruginosa 2A6 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12899,,Active,1869257,[],CHEMBL913077,Antimicrobial activity against Pseudomonas aeruginosa 2F6 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12900,,Active,1869269,[],CHEMBL913078,Antimicrobial activity against Pseudomonas aeruginosa 2A7 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12901,,Active,1869280,[],CHEMBL913079,Antimicrobial activity against Pseudomonas aeruginosa 2A9 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12902,,Active,1869283,[],CHEMBL913080,Antimicrobial activity against Pseudomonas aeruginosa 3B1 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12903,,Active,1869294,[],CHEMBL913081,Antimicrobial activity against Pseudomonas aeruginosa 65.68-1 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12904,,Active,1869305,[],CHEMBL913082,Antimicrobial activity against Pseudomonas aeruginosa 65.68-2 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12905,,Active,1869329,[],CHEMBL913083,Antimicrobial activity against Pseudomonas aeruginosa 65.68-3 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12906,,Active,1869345,[],CHEMBL913085,Antimicrobial activity against Pseudomonas aeruginosa 65.68-4 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12907,,Active,1869363,[],CHEMBL913086,Antimicrobial activity against Pseudomonas aeruginosa 2A5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12908,,Active,1869373,[],CHEMBL914688,Antimicrobial activity against Pseudomonas aeruginosa 3D1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12909,,Active,1869380,[],CHEMBL914689,Antimicrobial activity against Pseudomonas aeruginosa 3D10 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12910,,Active,1869390,[],CHEMBL914690,Antimicrobial activity against Pseudomonas aeruginosa 3E2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12911,,Active,1869412,[],CHEMBL914691,Antimicrobial activity against Pseudomonas aeruginosa 5F2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12912,,Active,1869424,[],CHEMBL914692,Antimicrobial activity against Pseudomonas aeruginosa 5F8 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12913,,Active,1869430,[],CHEMBL914693,Antimicrobial activity against Pseudomonas aeruginosa 5G3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12914,,Active,1869437,[],CHEMBL913084,Antimicrobial activity against Pseudomonas aeruginosa 5H6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12915,,Active,1869459,[],CHEMBL914694,Antimicrobial activity against Pseudomonas aeruginosa 8A2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12916,,Active,1869465,[],CHEMBL914695,Antimicrobial activity against Pseudomonas aeruginosa 8A12 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12917,,Active,1869471,[],CHEMBL914696,Antimicrobial activity against Pseudomonas aeruginosa 8C4 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12918,,Active,1869504,[],CHEMBL914697,Antimicrobial activity against Pseudomonas aeruginosa 8B11 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12919,,Active,1869510,[],CHEMBL914698,Antimicrobial activity against Pseudomonas aeruginosa 9A1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12920,,Active,1869516,[],CHEMBL914699,Antimicrobial activity against Pseudomonas aeruginosa 9A3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12921,,Active,1869522,[],CHEMBL914700,Antimicrobial activity against Pseudomonas aeruginosa 9A7 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12922,,Active,1869528,[],CHEMBL914701,Antimicrobial activity against Pseudomonas aeruginosa 9A10 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12923,,Active,1869561,[],CHEMBL914702,Antimicrobial activity against Pseudomonas aeruginosa 9B2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12924,,Active,1869567,[],CHEMBL914703,Antimicrobial activity against Pseudomonas aeruginosa 9B5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12925,,Active,1869573,[],CHEMBL914704,Antimicrobial activity against Pseudomonas aeruginosa 10A6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12926,,Active,1869585,[],CHEMBL914705,Antimicrobial activity against Pseudomonas aeruginosa 10A9 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12927,,Active,1869591,[],CHEMBL914706,Antimicrobial activity against Pseudomonas aeruginosa 10B1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12928,,Active,1869597,[],CHEMBL914707,Antimicrobial activity against Pseudomonas aeruginosa 10B3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12929,,Active,1869603,[],CHEMBL914708,Antimicrobial activity against Pseudomonas aeruginosa 12A3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12930,,Active,1869609,[],CHEMBL914136,Antimicrobial activity against Pseudomonas aeruginosa 12A7 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12931,,Active,1869620,[],CHEMBL914137,Antimicrobial activity against Pseudomonas aeruginosa 12B2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12932,,Active,1869641,[],CHEMBL913065,Antimicrobial activity against Pseudomonas aeruginosa 13D11 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12933,,Active,1869647,[],CHEMBL913066,Antimicrobial activity against Pseudomonas aeruginosa 13E1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12934,,Not Active,1869653,[],CHEMBL913067,Antimicrobial activity against Pseudomonas aeruginosa 15G2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12935,,Active,1869676,[],CHEMBL914141,Antimicrobial activity against Pseudomonas aeruginosa 15H5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12936,,Active,1869688,[],CHEMBL914143,Antimicrobial activity against Pseudomonas aeruginosa 16D5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12937,,Active,1869700,[],CHEMBL914145,Antimicrobial activity against Pseudomonas aeruginosa 19B3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12938,,Active,1869707,[],CHEMBL914146,Antimicrobial activity against Pseudomonas aeruginosa 19B6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12939,,Active,1869740,[],CHEMBL914148,Antimicrobial activity against Pseudomonas aeruginosa 19C5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12940,,Active,1869747,[],CHEMBL914149,Antimicrobial activity against Pseudomonas aeruginosa 19C7 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12941,,Not Active,1869759,[],CHEMBL914151,Antimicrobial activity against Pseudomonas aeruginosa 19D9 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12942,,Active,1869778,[],CHEMBL915645,Antimicrobial activity against Pseudomonas aeruginosa 19E2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12943,,Active,1869791,[],CHEMBL915647,Antimicrobial activity against Pseudomonas aeruginosa 19E9 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12944,,Active,1869815,[],CHEMBL915650,Antimicrobial activity against Pseudomonas aeruginosa 22D2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12945,,Active,1869825,[],CHEMBL915651,Antimicrobial activity against Pseudomonas aeruginosa 22D6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12946,,Active,1869831,[],CHEMBL915652,Antimicrobial activity against Pseudomonas aeruginosa 22D9 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12947,,Active,1869840,[],CHEMBL915654,Antimicrobial activity against Pseudomonas aeruginosa 22E3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12948,,Active,1869846,[],CHEMBL915655,Antimicrobial activity against Pseudomonas aeruginosa 22C5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12949,,Active,1869853,[],CHEMBL915656,Antimicrobial activity against Pseudomonas aeruginosa 24D1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12950,,Not Active,1869861,[],CHEMBL915657,Antimicrobial activity against Pseudomonas aeruginosa 24D5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12951,,Active,1869881,[],CHEMBL915660,Antimicrobial activity against Pseudomonas aeruginosa 24E5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12952,,Active,1869898,[],CHEMBL915663,Antimicrobial activity against Pseudomonas aeruginosa 24F4 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12953,,Active,1869902,[],CHEMBL915064,Antimicrobial activity against Pseudomonas aeruginosa 24G1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12954,,Active,1869909,[],CHEMBL915065,Antimicrobial activity against Pseudomonas aeruginosa 29F6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12955,,Active,1869918,[],CHEMBL915066,Antimicrobial activity against Pseudomonas aeruginosa 29G6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12956,,Active,1869925,[],CHEMBL915067,Antimicrobial activity against Pseudomonas aeruginosa 29G7 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12957,,Active,1869931,[],CHEMBL915068,Antimicrobial activity against Pseudomonas aeruginosa 29G8 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12958,,Active,1869937,[],CHEMBL915068,Antimicrobial activity against Pseudomonas aeruginosa 29G8 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12959,,Not Active,1869944,[],CHEMBL915069,Antimicrobial activity against Pseudomonas aeruginosa 29H1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12960,,Active,1869952,[],CHEMBL915653,Antimicrobial activity against Pseudomonas aeruginosa 22E1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,634883,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
12961,,,1879192,[],CHEMBL905612,Permeability coefficient through artificial membrane in presence of unstirred water layer by PAMPA,A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1143050,Bioorg Med Chem,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,637841,=,1,0,=,,LogP app,,,-6.71,CHEMBL612558,,ADMET,,,,LogP app,,,,-6.71
12962,,,1879334,[],CHEMBL905613,Permeability coefficient through artificial membrane in presence of stirred water layer,A,,,BAO_0002808,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1143050,Bioorg Med Chem,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,637841,=,1,0,=,,Papp,10^-6 cm/s,,0.18,CHEMBL612558,,ADMET,,,,Papp,10^-6 cm/s,,,0.18
12963,,,1879335,[],CHEMBL905613,Permeability coefficient through artificial membrane in presence of stirred water layer,A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1143050,Bioorg Med Chem,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,637841,=,1,0,=,,LogP app,,,-6.74,CHEMBL612558,,ADMET,,,,LogP app,,,,-6.74
12964,,,1879437,[],CHEMBL905620,"Partition coefficient, log P of the compound",P,,,BAO_0002130,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1143050,Bioorg Med Chem,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,637841,=,1,1,=,,LogP,,,-1.03,CHEMBL2362975,,No relevant target,,,,LogP,,,,-1.03
12965,,Not Active,1917544,[],CHEMBL894357,Antibacterial activity against multidrug resistant Staphylococcus aureus 49589,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1148734,J Med Chem,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,654126,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
12966,,Not Determined,1951950,[],CHEMBL893613,Inhibition of bacterial DNA gyrase,B,,,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147922,Bioorg Med Chem Lett,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,651100,,1,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
12967,,Not Determined,1951979,[],CHEMBL893614,Inhibition of bacterial DNA topoisomerase 4,B,,,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147922,Bioorg Med Chem Lett,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,651100,,1,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
12968,,Not Determined,1952051,[],CHEMBL893615,Antibacterial activity against Escherichia coli KL16,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147922,Bioorg Med Chem Lett,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,651100,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
12969,,,1952773,[],CHEMBL893616,Antibacterial activity against Staphylococcus aureus ATCC 13709,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147922,Bioorg Med Chem Lett,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,651100,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
12970,,Not Determined,1952817,[],CHEMBL893617,Antibacterial activity against Streptococcus pneumoniae ATCC 49619,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147922,Bioorg Med Chem Lett,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,651100,,1,0,,,MIC,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,,,,
12971,,,1952907,[],CHEMBL893618,Antibacterial activity against quinolone susceptible methicillin resistant Staphylococcus aureus OC2878,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147922,Bioorg Med Chem Lett,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,651100,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
12972,,,1952928,[],CHEMBL893619,Antibacterial activity against ciprofloxacin resistant methicillin resistant Staphylococcus aureus OC3946,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147922,Bioorg Med Chem Lett,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,651100,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
12973,,,1952953,[],CHEMBL893620,Antibacterial activity against ciprofloxacin resistant methicillin resistant Staphylococcus aureus OC4159,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147922,Bioorg Med Chem Lett,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,651100,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
12974,,,1952976,[],CHEMBL892585,Antibacterial activity against ciprofloxacin resistant methicillin resistant Staphylococcus aureus OC4222,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147922,Bioorg Med Chem Lett,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,651100,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
12975,,,1952992,[],CHEMBL892586,Antibacterial activity against ciprofloxacin resistant methicillin resistant Staphylococcus aureus OC5273,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1147922,Bioorg Med Chem Lett,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,651100,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
12976,,,2021603,[],CHEMBL903530,Antimicrobial activity against fluoroquinolone-resistant Staphylococcus aureus SA1199B,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1139132,Bioorg Med Chem Lett,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,671729,=,1,1,=,,MIC,nM,,100000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,100.0
12977,,,2052206,[],CHEMBL942812,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1140570,Bioorg Med Chem Lett,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,680990,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
12978,,,2052213,[],CHEMBL941868,Antibacterial activity against Escherichia coli ATCC 25922 by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1140570,Bioorg Med Chem Lett,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,680990,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
12979,,,2052220,[],CHEMBL941869,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1140570,Bioorg Med Chem Lett,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,680990,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
12980,,,2052228,[],CHEMBL941870,Antibacterial activity against Bacillus subtilis ATCC 6033 by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1140570,Bioorg Med Chem Lett,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,680990,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,32.0
12981,,,2052236,[],CHEMBL941871,Antibacterial activity against Staphylococcus aureus ATCC 25923 by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1140570,Bioorg Med Chem Lett,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,680990,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
12982,,,2052244,[],CHEMBL941872,Antibacterial activity against Streptococcus faecalis ATCC 29212 by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1140570,Bioorg Med Chem Lett,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,680990,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,8.0
12983,,,2063492,[],CHEMBL943135,Antibacterial activity against multidrug-resistant Staphylococcus aureus 1199B overexpressing NorA after 18 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1141428,J Nat Prod,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,684993,=,1,1,=,,MIC,nM,,100000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,100.0
12984,,,2126258,[],CHEMBL934997,Antibacterial activity against CTX-M group 1 enzyme producing Escherichia coli isolates by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702314,>,1,1,>,,MIC50,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,8.0
12985,,,2126259,[],CHEMBL934997,Antibacterial activity against CTX-M group 1 enzyme producing Escherichia coli isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702314,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,8.0
12986,,,2126293,[],CHEMBL934998,Antibacterial activity against CTX-M group 1 enzyme producing Escherichia coli isolates assessed as percent resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,702314,=,1,0,=,,Activity,%,,98.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,98.0
12987,,,2126311,[],CHEMBL934999,Antibacterial activity against CTX-M group 1 enzyme producing Escherichia coli isolates assessed as percent nonsusceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,702314,=,1,0,=,,Activity,%,,98.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,98.0
12988,,,2126332,[],CHEMBL935000,Antibacterial activity against CTX-M group 9 enzyme producing Escherichia coli isolates by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702314,<=,1,1,<=,,MIC50,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,2.0
12989,,,2126333,[],CHEMBL935000,Antibacterial activity against CTX-M group 9 enzyme producing Escherichia coli isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702314,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,8.0
12990,,,2126369,[],CHEMBL935001,Antibacterial activity against CTX-M group 9 enzyme producing Escherichia coli isolates assessed as percent resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,702314,=,1,0,=,,Activity,%,,33.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,33.0
12991,,,2126387,[],CHEMBL935002,Antibacterial activity against CTX-M group 9 enzyme producing Escherichia coli isolates assessed as percent nonsusceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,702314,=,1,0,=,,Activity,%,,33.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,33.0
12992,,,2127974,[],CHEMBL935952,Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 after 16 hrs by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703979,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
12993,,,2127975,[],CHEMBL935952,Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 after 16 hrs by serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703979,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,1.0
12994,,,2127978,[],CHEMBL935953,Antibacterial activity against Escherichia coli K12 mutant JHU313 after 16 hrs by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703979,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
12995,,,2127979,[],CHEMBL935953,Antibacterial activity against Escherichia coli K12 mutant JHU313 after 16 hrs by serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703979,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.5
12996,,,2127982,[],CHEMBL935954,Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid PhoU after 16 hrs by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703979,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
12997,,,2127983,[],CHEMBL935954,Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid PhoU after 16 hrs by serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703979,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,1.0
12998,,,2127986,[],CHEMBL935955,Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid vector after 16 hrs by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703979,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
12999,,,2127987,[],CHEMBL935955,Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid vector after 16 hrs by serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703979,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.5
